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Abstract
Accounting for time-varying confounding when assessing causal effects of time-
varying exposures on survival time is challenging. Standard survival methods that
incorporate time-varying confounders as covariates generally yield biased effect
estimates. Estimators using weighting by inverse probability of exposure can be
unstable when confounders are highly predictive of exposure or the exposure is
continuous. Structural nested accelerated failure time models require artificial
recensoring, which can cause estimation difficulties. Here, we introduce the struc-
tural nested cumulative survival time model (SNCSTM). This model assumes
that intervening to set exposure at time t to zero has an additive effect on the
subsequent conditional hazard given exposure and confounder histories when all
subsequent exposures have already been set to zero. We show how to fit it using
standard software for generalised linear models and describe two more efficient,
double robust, closed-form estimators. All three estimators avoid the artificial
recensoring of accelerated failure time models and the instability of estimators that
use weighting by the inverse probability of exposure. We examine the performance
of our estimators using a simulation study and illustrate their use on data from the
UK Cystic Fibrosis Registry. The SNCSTM is compared with a recently proposed
structural nested cumulative failure time model, and several advantages of the
former are identified.




Observational studies that attempt to assess the effect of a time-varying exposure
on a survival outcome typically suffer from time-varying confounding bias. Such
bias is the result of time-varying factors that both influence exposure and are associ-
ated with survival, thereby distorting the association between the two. For example,
studies of the effect of hospital-acquired pneumonia on time to death (since hospital
admission) in critically ill patients are confounded by disease severity, because
disease severity influences susceptibility to pneumonia infection and is strongly
associated with mortality (Bekaert et al., 2010). Time-varying confounders (e.g.
disease severity) are often affected by earlier exposures (e.g. pneumonia infection).
This induces feedback relationships between exposures and confounders over time
that cannot be untangled via traditional survival analysis regression methods that
adjust for time-varying covariates, such as history of exposure and confounders, at
each timepoint (Robins et al., 2000). The reason for this is two-fold. First, such
adjustment procedures eliminate indirect effects of early exposures on survival that
are mediated through those confounders. For example, it would be undesirable to
eliminate effects of hospital-acquired pneumonia on survival that are mediated
through disease severity, as scientific interest is primarily in the overall effect of
infection. Second, such adjustment procedures are prone to collider-stratification
biases that can render exposure and outcome dependent even in the absence of an
exposure effect. See Daniel et al. (2013) for a review of these difficulties.
Time-varying confounding has received much attention in the causal inference liter-
ature. For survival time outcomes, the two main approaches are based on structural
nested accelerated failure time models (AFTMs) (Robins and Tsiatis, 1991; Robins
and Greenland, 1994) and marginal structural models (MSMs) (Robins et al.,
2000). The latter approach is more popular, because of its greater simplicity and
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flexibility. In particular, accounting for non-informative censoring in MSMs does
not, unlike in structural nested AFTMs, require an ‘artificial recensoring’ procedure
in which originally uncensored subjects may become censored. Avoiding this re-
censoring is advantageous, because recensoring causes information loss, which can
result in poor estimators and difficulties solving the estimating equations (Joffe
et al., 2012). However, fitting MSMs relies on inverse weighting by the probability
of exposure, which has it own drawback: estimators prone to large finite-sample
bias and variance when confounders are highly predictive of the exposure, or when
the exposure is continuous or discrete with many levels.
More recently, Young et al. (2010) and Picciotto et al. (2012) proposed a new class
of discrete-time structural nested cumulative failure time models, which parame-
terize the effect of the exposure at each time t on the outcome at each later time in
terms of the ratio of two (possibly) counterfactual cumulative failure risks at that
later time under exposure regimes that differ only at time t. Their procedure has
the desirable properties of structural nested AFTMs — viz. by avoiding inverse
probability weighting, it handles continuous exposures without estimators being
subject to large bias and variance, and it allows modelling of effect modification
by time-varying covariates — while avoiding the need for artificial recensoring.
Here, we use developments by Martinussen et al. (2011) and Dukes et al. (2019)
(hereafter DMTV). The former showed how to adjust for time-varying confounding
when effects of exposure and confounders are parameterized on the additive hazard
scale. They focused on the simple setting where interest is in estimating the direct
effect of a binary baseline exposure on a survival outcome, i.e. the effect not medi-
ated by a given intermediate variable, and where there are no baseline confounders.
DMTV proposed an additive hazards model for the effect of a baseline exposure
on survival time conditional on baseline confounders and derived the efficient score
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when (as assumed by Martinussen et al.) the confounders act additively on the
hazard; this additivity assumption is not needed for consistency of their estimators.
Here, we propose a novel class of semiparametric structural nested cumulative
survival time models (SNCSTMs), of which the models of Martinussen et al. (2011)
and DMTV are special cases, and propose three estimators of its parameters. Our
model allows baseline and time-varying confounders, binary or continuous expo-
sure, any number of exposure measurement times and the option of constraining ex-
posure effects to be common at different times; it does not parameterise the effects
of confounders on the baseline hazard. It also allows investigation of exposure effect
modification by time-varying factors. The SNCSTM is closely related to Picciotto
et al.’s model, and our estimators share the forementioned desirable properties of
the latter. The SNCSTM generalises Picciotto et al.’s model to continuous time
and parameterises relative survival risks instead of failure risks. Our approach has
several advantages over that of Picciotto et al. One of our estimators (Method
1) can be calculated using GLM software. Our other two estimators (Methods 2
and 3) are more efficient, double robust and available in closed form. All three
estimators automatically handle random censoring. Also, because parameterised
in continuous time, SNCSTMs can handle irregular measurement times and allow
interpretation of parameters in terms of hazards.
We define notation and state fundamental assumptions in Section 2. A simple
version of our SNCSTM is introduced in Section 3. In Section 4, we propose
three methods for estimating its parameters. The general SNCSTM is described
in Section 5. In Section 6, we discuss random censoring. A simulation study is
described in Section 7. Section 8 describes an analysis of data from the UK Cystic
Fibrosis (CF) Registry, looking at the effect of treatment with DNase on survival
in people with CF. We conclude with a discussion in Section 9.
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2. Notation and assumptions
Consider a study in which, for each of n subjects, a time-varying exposure and
vector of possibly time-varying confounders are measured at time zero and at up
to K follow-up visits. Until Section 5 we assume the follow-up times are regular,
i.e. the same for all individuals, and (for notational simplicity) are 1, 2, . . . , K, and
that all individuals are administratively censored at time K+1. Until Section 6 we
assume there is no censoring apart from this administrative censoring. If visits are
regular but not at times 1, . . . , K, or if administrative censoring occurs at a time
different from K + 1 or not at all, this can easily be accommodated by rescaling
the time variable within each interval between consecutive visits.
Let Ti denote individual i’s failure time, and Aki and Lki denote, respectively,
his exposure and vector of confounders measured at time k (k = 0, . . . , K). Let
Ri(t) = I(Ti > t) be the at-risk indicator. If individual i fails before his kth visit,
Aki and Lki are defined as zero. Let Āki = (A0i, . . . , Aki)
⊤, L̄ki = (L0i, . . . , Lki)
⊤
and A−1,i ≡ ∅. The causal ordering of the variables is {L0, A0, T ∧ 1, L1, A1, T ∧
2, . . . , LK , AK , T ∧ (K + 1)}, where x ∧ y means the minimum of x and y.
Define Ti(Āki, 0) as individual i’s (possibly) counterfactual failure time that would
have applied if his exposures up to the kth visit had been as observed and his
exposures from the (k+1)th visit onwards had been set to zero by an intervention.
We make the consistency assumption that Ti = T (Āk,i, 0) with probability one
for individuals with Ak+1,i = . . . = AKi = 0. Note T (Āk−1,i, 0) > k if and only
if T (Āli, 0) > k for all l = k, . . . , K, i.e. intervening on an exposure can only
affect survival after the time of that exposure. It follows that events {Ti > t}
and {Ti(Aki, 0) > t} are equivalent when t ∈ [k, k + 1). We assume (ĀKi, L̄Ki, Ti)
(i = 1, ..., n) are i.i.d and henceforth omit the subscript i unless needed.
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We make the following sequential no unmeasured confounders assumption (NUC):
T (Āk−1, 0) ⊥⊥ Ak | L̄k, Āk−1, T > k (k = 0, . . . , K) (Robins, 1986). That is, among
individuals who are still alive (or event-free) at time k, the assigned exposure Ak at
time k may depend on L̄k and Āk−1, but given these, has no residual dependence
on the remaining lifetime that would apply if all future exposures were set to zero.
3. Structural Nested Cumulative Survival Time Model (SNCSTM)
We first introduce a simple version of the SNCSTM that does not allow for exposure
effect modification. The more general SNCSTM is described in Section 5.
For each k = 0, . . . , K, let Mk be the model defined by the restriction
P{T (Āk, 0) > t | Āk, L̄k, T > k}
P{T (Āk−1, 0) > t | Āk, L̄k, T > k}
= exp{−Akvk(t)
⊤ψk}, (1)
∀t > k, where ψk = (ψk(k), ψk(k+1), . . . , ψk(K))
⊤ is a vector of of K−k+1 unknown
parameters, and vk(t) equals (t − k, 0, . . . , 0)
⊤ if t ∈ [k, k + 1), equals (1, t − k −
1, 0, . . . , 0)⊤ if t ∈ [k+1, k+2), and equals (1, 1, t−k−2, 0, . . . , 0)⊤ if t ∈ [k+2, k+3),
etc. So, for any k 6 l 6 t < l + 1, vk(t)
⊤ψk equals ψk(k) + . . . ψk(l−1) + ψk(l)(t− l).
Equation (1) means that among the survivors in the population at the kth visit
time, in the stratum defined by any given (Āk, L̄k) the proportion who survive to
a later time t when exposures from visit k + 1 onwards (i.e. Ak+1, . . . , AK) have
already been set to zero would be multiplied by exp{Akvk(t)
⊤ψk} if exposure Ak
were also set to zero. Hence, vk(t)
⊤ψk is the (controlled) direct effect of Ak on the
probability of survival to time t given survival to visit k, i.e. the effect of Ak not
mediated through the later exposures Ak+1, . . . , Al. E.g., if ψk(k), . . . , ψk(K) are all
positive and Ak > 0, then intervening to set Ak = 0 is beneficial, i.e. exposure is
harmful. Conversely, if ψk(k), . . . , ψk(K) are all negative, exposure is beneficial. This
SNCSTM assumes the direct effect vk(t)
⊤ψk is the same for any history (Āk−1, L̄k).
In Section 5 we extend the SNCSTM to allow the effect to depend on the history.
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By taking logs of each side of equation (1) and differentiating with respect to t, it
can be shown that Model Mk can also be written as
E
{




dN(Āk ,0)(t) | Āk, L̄k, T (Āk, 0) > t
}
−Akψk(l) dt (2)
for t ∈ [l, l + 1) (with l = k, . . . , K), where N(Āk,0)(t) = I{T (Āk, 0) 6 t} is the
counting process for T (Āk, 0). Equation (2) can be interpreted as follows. In a
stratum defined by (Āk, L̄k) and T > k, the hazard of failure at any time between
visits l and l + 1 (l > k) when Ak+1, . . . , Al have already been set equal to zero
would be reduced by Akψk(l) if Ak were also set to zero.
Note that Model Mk treats E
{





dN(Āk−1,0)(t) | Āk−1, L̄k, T (Āk−1, 0) > t
}
— as a totally unspeci-
fied ‘baseline’ hazard, rather than parameterising its dependence on Āk−1 and
L̄k. One advantage of this is that the danger of incompatibility between Models
M0, . . .MK is avoided. To illustrate this danger, suppose it were assumed that
E
{
dN(t) | Ā1, L̄1, T > t
}
= φ10(t)+φ1A0(t)A0+φ1L̄1(t)
⊤L̄1+ψ1(1)A1 for all t > 1.
This, together with NUC, implies M1 holds. However, it also implies a restriction
on the association between A0 and T , a restriction which might conflict with that
of M0. Such conflict would be the result of there being no coherent overall model.
4. Estimation methods
In order to estimate ψk(l), we introduce nuisance Models Ak (k = 0, . . . , K). Model
Ak is a generalised linear model (GLM) for Ak given Āk−1, L̄k and T > k with
g{E(Ak | Āk−1, L̄k, T > k)} = α
⊤
k0Hk, where αk0 is an unknown finite-dimensional
parameter and Hk = Hk(Āk−1, L̄k) is a known vector function of (Āk−1, L̄k) whose
first element equals 1, e.g. Hk = (1, Ak−1, L
⊤
k )
⊤. The dispersion parameter φk is
assumed not to depend on Āk−1 or L̄k, and g is the canonical link function. The
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methods described in Sections 4.1–4.3 consistently estimate ψk(l) when Models
Mk and Ak (k = 0, . . . , K) are correctly specified. Method 1 can be applied using
standard GLM software. Methods 2 and 3 improve on Method 1 by using more
efficient estimators that are closely related to that described by DMTV in the
setting of a single baseline exposure. Method 3 gives consistent estimation under
slightly weaker conditions than Method 2, but is more computationally intensive.
4.1 Method 1: fitting the GLM implied by Models Mk and Ak
Model Ak states that Ak given Āk−1, L̄k and T > k obeys a GLM. Bayes’ rule
shows (see Web Appendix A) that Models Ak,Mk, . . . ,MK and NUC together
imply that, for any t > k, Ak given Āk−1, L̄k and T (Āk, 0) > t obeys the same
GLM but with the intercept shifted by a function of t. Specifically, for t > k,





where αk = (αk(k), . . . , αk(K))
⊤ and αk(l) = −ψk(l)φk (l = k, . . . , K). Our first esti-
mation method for ψk(l) involves fitting this GLM to estimate αk(l) and calculating
ψk(l) = −αk(l)/φk. We now explain in more detail.
First we estimate ψk(k) (k = 0, . . . , K) as follows. For t ∈ [k, k + 1), events
{T (Āk, 0) > t} and {T > t} are equivalent, and so equation (3) implies g{E(Ak |
Āk−1, L̄k, T > t)} = α
⊤
k0Hk +αk(k)(t− k) for any t ∈ [k, k+ 1). Hence, a consistent
estimate α̂k(k) of αk(k) can be obtained as follows. For each of a number (we used 10)
of equally spaced values of t between k and k+1 (including k and k+ 1), identify
the set of individuals with T > t and, for each of these individuals, create a copy
(a ‘pseudo-individual’) with the same value of (ĀK , L̄K) and with new random
variable Q equal to t. Fit the GLM g{E(Ak | Āk−1, L̄k, Q)} = α
⊤
k0Hk+αk(k)(Q−k)
to the resulting set of (up to 10n) pseudo-individuals. A consistent estimate of ψk(k)
is then ψ̂M1k(k) = −α̂k(k)/φk. When φk is unknown, it can be estimated by fitting
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Model Ak to those of the original n individuals with T > k. In the simulation
study of Section 7, we also tried using 50 values of t to construct the set of pseudo-
individuals instead of 10, but found this made very little difference to the estimates.
Next we estimate ψk(k+1) (k = 0, . . . , K−1). When t ∈ [k+1, k+2), equation (3) is
g{E(Ak | Āk−1, L̄k, T (Āk, 0) > t)} = α
⊤
k0Hk+αk(k)+αk(k+1)(t−k−1). If Ti(Āki, 0)
were known for all i, ψk(k+1) could be estimated just as ψk(k) was, but it is not.
However, as shown in Web Appendix B, Mk, . . . ,MK imply that for t > k + 1,
P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > k} = E
{










. That is, within the population stratum
defined by any given value of (Āk, L̄k) and by T (Āk, 0) > k (or equivalently T > k),
the proportion of individuals with T (Āk, 0) > t is equal to the proportion of indi-
viduals with T > t after weighting each individual by wk(t). Remembering that the
first element ofHk equals one for all individuals, it follows that a consistent estimate
α̂k(k+1) of αk(k+1) can be obtained by fitting the GLM g{E(Ak | Āk−1, L̄k, Q)} =
α⊤k0Hk +αk(k+1)(Q− k− 1) to a set of pseudo-individuals constructed as described
above but using ten values of t between k+1 and k+2 (rather than k and k+1) and
using weights wk(Q) = exp{Ak+1ψk+1(k+1)(Q−k−1)}. The weights wk(Q) depend
on ψk+1(k+1), which is unknown, and so we replace it by its previously obtained
estimate ψ̂M1k(k). A consistent estimate of ψk(k+1) is then ψ̂
M1
k(k+1) = −α̂k(k+1)/φk.
In general, ψk(l) (0 6 k 6 l 6 K) is estimated by ψ̂
M1
k(l) = −α̂k(l)/φk, where α̂k(l) is
the estimate of αk(l) obtained by fitting the GLM
g{E(Ak | Āk−1, L̄k, Q)} = α
⊤
k0Hk + αk(l)(Q− l) (5)
to a set of pseudo-individuals constructed using ten equally spaced values of t
between l and l + 1 and using weights wk(Q), with ψj(m) replaced by ψ̂
M1
j(m). For
later reference, we denote the fitted value of E(Ak | Āk−1, L̄k, Q = t) thus obtained
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as êk(l)(Āk−1, L̄k, t). This is an estimate of E(Ak | Āk−1, L̄k, T (Āk, 0) > t). Note
that ψ̂M1j(m) (k < j 6 m 6 l) must be calculated before ψ̂
M1
k(l). If φk is unknown, it is
estimated by fitting Model Ak to the original individuals with T > k.
Although this estimation procedure involves weights wk(t), these are different from
the inverse probability of exposure weights used to fit MSMs and do not suffer
the same instability that can plague the latter weights. In particular, if ψk(k) =
. . . = ψk(K) = 0, i.e. Ak has no direct effect on survival, then wk(t) = 1. The
variance of the weights can be reduced by using modified (or ‘stabilised’) weights











Aj − E(Aj | Āk−1, L̄k, T > j) (j = k + 1, . . . , K). This may improve efficiency,
especially when Aj is precisely predicted by (Āk−1, L̄k). The ratio w
∗
k(Q)/wk(Q)
depends only on Āk−1 and L̄k, and as model (5) is conditional on these, α̂k(l)
remains consistent. Since E(Aj | Āk−1, L̄k, T > j) (j = k + 1, . . . , K) is unknown,
a working model Cj(k) is specified for it and its parameters estimated from the set
of individuals still at risk at time j. Note that Cj(k) does not need to be correctly
specified for ψ̂k(l) to be consistent; indeed Cj(k) need not be compatible with Ak.
4.2 Method 2: g-estimation
The principle underlying the following estimator of ψk(l) is that after removing
the effects of Ak and later exposures from the increment in the counting process
N(t) = I(T > t), NUC implies that the resulting ‘blipped down’ increment at any
time t > k is independent of Ak conditional on Āk−1 and L̄k and being still at risk.











where ∆k(t) = Ak − E(Ak | Āk−1, L̄k, T (Āk, 0) > t). The expectation E(Ak |
Āk−1, L̄k, T (Āk, 0) > t) is unknown, so we replace it by êk(k)(Āk−1, L̄k, t), obtained
exactly as in Method 1. The next paragraph provides a rationale for equation (6).
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NUC implies that counting process N(Āk−1,0)(t) = I(T (Āk−1, 0) 6 t) for T (Āk−1, 0)
is conditionally independent of Ak given Āk−1, L̄k and T (Āk−1, 0) > k. We do not
observe N(Āk−1,0)(t), but equation (2) relates N(Āk−1,0)(t) to N(Āk,0)(t), the counting
process for T (Āk, 0), and we do observe N(Āk,0)(t) when t ∈ [k, k+1), because then
it equals N(t) = I(T 6 t), the counting process for the observed failure time T .
In particular, equation (2) implies that, for any t ∈ [k, k + 1) and conditional on
(Āk, L̄k), the expected increment in N(Āk−1,0)(t) during short time interval (t, t+ δ]
given T (Āk−1, 0) > t can be unbiasedly estimated by the corresponding mean of
the observed increments in N(t) minus Akψk(k)δ among the survivors at time t.
Hence, the adjusted observed increment N(t + δ) − N(t) − Akψk(k)δ should be
uncorrelated with Ak given (Āk−1, L̄k−1) and T > t.
DMTV derived the semiparametric efficient estimating equation for ψk(k) under
Model Mk assuming known distribution of Ak given (Āk−1, L̄k) and t > k. This
equation involves inverse weighting by the hazard function; such weighting also fea-
tures in efficient estimating equations of other additive hazards models. In practice,
accurate estimation of the hazard function is difficult and increases the computa-
tional complexity of the procedure, and so this weighting is commonly omitted
by standard fitting procedures for additive hazards models. Results of DMTV
imply (see Web Appendix C) that if this is done with the semiparametric efficient
equation for ψk(k) under Model Mk and if E{dN(Āk−1,0)(t) | Āk, L̄k, T (Āk−1, 0) >
t} = γ⊤k(k)Hk for all t ∈ [k, k + 1), the result is equation (6).
To make equation (6) invariant to additive transformations of Ak, we replace
Akiψk(k) by ∆ki(k)ψk(k). Since E(Ak | Āk−1, L̄k, T (Āk, 0) > k) is a constant given
(Āk−1, L̄k−1), this does not affect the unbiasedness of the estimating equations. Let
ψ̂M2k(k) denote the resulting estimator of ψk(k).
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= 0. The un-
known E(Ak | Āk−1, L̄k, T (Āk, 0) > t) and ψk+1(k+1) are replaced by êk(k+1)(Āk−1, L̄k, t)
and ψ̂M2k+1(k+1). The next paragraph provides a rationale for this estimating equation.
Again we exploit the conditional independence of N(Āk−1,0)(t) and Ak (NUC) and
the relation between N(Āk−1,0)(t) and N(Āk,0)(t), but now over time interval [k +
1, k+ 2). An added complication is that N(Āk,0)(t) is not observed when t > k+ 1.
However, we know from equation (2) that when t ∈ [k+ 1, k+2) the intensities of
N(Āk,0)(t) and N(t) = N(Āk+1,0)(t) differ by Ak+1ψk+1(k+1) and (as noted in Section
4.1) there are wk(t) = exp{Ak+1 ψk+1(k+1)(t−k−1)} times as many individuals with
T (Āk, 0) > t in the population as there are with T (Āk+1, 0) > t. So, we can unbias-
edly estimate the expected increment in N(Āk−1,0)(t) over small interval [t, t+ δ) as
the weighted mean of the increments in N(t) minus (Ak+1ψk+1(k+1) + Akψk(k+1))δ
with weights exp{Ak+1ψk+1(k+1)(t − k − 1)}. This justifies the above estimating
equation but with Akiψk(k+1) in place of ∆ki(k+1)ψk(k+1). We use ∆ki(k+1)ψk(k+1)
instead for the same reason that we replaced Akiψk(k) by ∆ki(k)ψk(k) in equation (6).



















with E(Ak | Āk−1, L̄k, S̄, T (Āk, 0) > t) replaced by êk(l)(Āk−1, L̄k, t) and ψj(l) (j >
k) replaced by ψ̂M2j(l); this requires that ψj(m) (k < j 6 m 6 l) be estimated before
ψk(l). The estimator ψ̂
M2
k(l) is available in closed form (see Web Appendix E for
formulae when g(.) is the identity or logistic link function).
In Web Appendix F we prove ψ̂M2k(l) is double robust in the following sense. Let
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e∗k(l)(Āk−1, L̄k, t) denote the limit as n → ∞ of êk(l)(Āk−1, L̄k, t), and let Model





k(l)(Āk−1, L̄k, k) ψk(l)
}
dt ∀t ∈ [l, l + 1), where γk(l) are unknown
parameters. ψ̂M2k(l) is consistent if 1) Mk, . . . ,Ml, 2) either Ak or Bk(l), and 3) for
each j = k + 1, . . . , l, either Aj or all of Bj(j), . . . ,Bj(l) are correctly specified. The
term e∗k(l)(Āk−1, L̄k, k)ψk(l) in Model Bk(l) arises because of the use of ∆k(l)ψk(l),
rather than Akψk(l), in equation (7) (see proof). Note that if ψk(l) = 0 or Ak is
a linear regression, so that e∗k(l)(Ak, L̄k, k) ψk(l) is a linear function of Hk, it can
be omitted. As in Method 1, efficiency may be gained by using stabilised weights
w∗ki(t) in place of wki(t) in equation (7). Also, to make ψ̂
M2
k(l) invariant to additive
transformations of Ak+1, . . . , Al, the term Ajiψj(l) can be replaced by ∆
∗
j(k),iψj(l).
4.3 Method 3: improved g-estimation
If we use a different estimator êk(l)(Āk−1, L̄k, t) of E(Ak | Āk−1, L̄k, T (Āk, 0) > t)
for the ∆k(t) and ∆k(l) terms in equation (7), then the estimator solving (7)
remains consistent under a more general version of Model Bk(l). In Methods 1
and 2, êk(l)(Āk−1, L̄k, t) is calculated by fitting a single GLM to a set of pseudo-
individuals, with time since lth visit, Q− l, as a covariate. In Method 3, we instead
fit a separate GLM at each time since the lth visit. That is, for any t > 0, we
calculate êk(l)(Āk−1, L̄k, t) by fitting the GLM g{E(Ak | Āk−1, L̄k)} = αk0(t)
⊤Hk
to the set of individuals with T > t, using weights wk(t). This set changes only
at times t at which an individual leaves the risk set, and so the GLM needs to
be fitted only at these times. This is the approach taken by DMTV, who denoted
the resulting estimator of ψk(k) as “ψ̂TVPS−DR” and, on the basis of results from a
simulation study, recommended it over three alternatives. As in Method 2, we can
use stabilised weights and replace Ajψj(l) by ∆
∗
j(k)ψj(l). As shown in Web Appendix
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F, Method 3 has the same double robustness property as Method 2 but with the
parameters γk(l) in Model Bk(l) now allowed to be a function of t− l.
4.4 Constraining exposure effects
In some applications, it may be desirable to impose the constraint that ψk(k+m) =
ψk′(k′+m) for all k, k
′, m, i.e. the effect of exposure measured at one visit k on the
hazard m visits later is the same for all k. This reduces the number of parameters
and, as we see in Section 7, increases the precision of their estimates. In Web
Appendix G we explain how estimation may be performed under this constraint.
See Vansteelandt and Sjolander (2016) for how to impose other constraints.
5. The general SNCSTM
In this section, we extend the SNCSTM to allow visit times to be irregular, i.e.
to vary from one individual to another, and effect modification, i.e. the effect of
exposure on survival to depend on the exposure and confounder histories.
Let Ski denote the time of individual i’s kth follow-up visit (k = 1, . . . , K), and let
S0i = 0 (i = 1, . . . , n) and S̄i = (S1i, . . . , SKi)
⊤. Until now, we have assumed Ski =
k ∀i. We assume visit times S̄ are planned or randomly chosen at baseline using only
baseline confounder information, i.e. L0, and we modify NUC to be T (Āk−1, 0) ⊥⊥
Ak | L̄k, Āk−1, S̄, T > Sk (k = 0, . . . , K). Also, let SK+1,i denote an administrative
censoring time common to all individuals (until now, we assumed SK+1,i = K+1).
If there is no such time, let SK+1,i = ∞. To allow effect modification, we define
Zk(l) = (1, Z
int⊤
k(l) )
⊤, where Z intk(l) is a known (possibly vector) function of (Āk−1, L̄k, S̄)
(‘int’ stands for ‘interactions’), and let Zk = (Z
⊤




For each k = 0, . . . , K, let Mk be the model defined by the restriction
P{T (Āk, 0) > t | Āk, L̄k, S̄, T > Sk}
P{T (Āk−1, 0) > t | Āk, L̄k, S̄, T > Sk}
= exp{−Akvk(t, Zk, S̄)
⊤ψk}, (8)




k(k), 0, . . . , 0
)⊤
if t ∈ [Sk, Sk+1), equals
(
(Sk+1−





k(k+1), 0, . . . , 0
)⊤









k(k+2), 0, . . . , 0
)⊤
if t ∈ [Sk+2, Sk+3), etc. If Sk = k
and Zk(l) = 1, equation (8) reduces to equation (1). Model Mk can also be written
asE
{








k(l)Zk(l) dt for t ∈ [Sl, Sl+1).
The modifications to Methods 1 and 2 needed to fit the general SNCSTM are
simple (see Web Appendix D). Modifying Method 3 is simple when visit times are
regular; it is possible for irregular visit times, but is fiddly. In the simulation study
reported in Section 7 we found little benefit from Method 3 relative to Method 2
when visit times were regular, and so did not implement it for irregular times.
6. Censoring
We now allow for censoring before the administrative censoring time. Let Ci and
T̃i denote individual i’s censoring and failure times, respectively. Redefine Ti and
Ni(t) as Ti = T̃i ∧ Ci and Ni(t) = I(Ti 6 t, Ti < Ci); Ri(t) is unchanged except
that Ti has this new meaning. With these changes, Methods 1–3 remain valid,
provided two further conditions hold (Vansteelandt and Sjolander, 2016). First,
the censoring hazard does not depend on the exact failure time or future exposures
or confounders. That is, the counting process, NC(t) = I(C 6 t), for the censoring
time satisfies E{dNC(t) | C > t, Ā⌊T̃ ⌋, L̄⌊T̃ ⌋, S̄, T̃ > t, T̃} = λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) ∀t,
where Ā⌊t⌋ and L̄⌊t⌋ are the exposure and confounder histories up to time t and
λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) is some function only of (t, Ā⌊t⌋, L̄⌊t⌋, S̄). The second condition,
which can be weakened by using censoring weights (see Web Appendix H), is that
λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) = λ(t, L0, S̄), so censoring depends only on baseline confounders.
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7. Simulation study
We used a simulation study to investigate bias and efficiency of the methods. There
were K + 1 = 4 visits and two time-dependent confounders (i.e. dim(Lk) = 2).
These and the exposure were generated as: L0 ∼ N ((0, 0), Σ), A0 ∼ N(3 +
(0.2, 0.1)⊤L0, 0.9
2), Lk ∼ N
(
ΩLk−1 + (0.1, 0.05)
⊤Ak−1, Σ
)
and Ak ∼ N(3 +
(0.1, 0.05)⊤Lk, 0.7



















The hazard of failure during the interval between the kth and (k + 1)th visits was
0.34 + (0.03, 0.03)⊤Lk − 0.04Ak − 0.0145Ak−1I(k > 1) − 0.0055Ak−2I(k > 2) −
0.00245Ak−3I(k = 3). For this data-generating mechanism, Mk (k = 0, . . .K) is
correctly specified with no effect modification (i.e. Zk(l) = 1) and the true exposure
effects are ψk(k) = −0.04, ψk(k+1) = −0.01, ψk(k+2) = −0.004 and ψk(k+3) = −0.002.
We considered three scenarios: two with regular and one with irregular visit times.
For regular visits, Sik = k. For irregular visits, inter-visit times Sk+1,i−Ski were in-
dependently uniformly distributed on [0.5, 1.5]. There was administrative censoring
at time 4. In one of the regular visit scenarios, there was no random censoring. In
the other, and in the irregular visit scenario, there was an exponentially distributed
random censoring time with mean 5. For the regular visit scenario without random
censoring, the expected percentages of individuals observed to fail between visits 0
and 1, 1 and 2, 2 and 3, and between visit 3 and time 4 were 20%, 14%, 11% and 9%,
respectively. For the regular and irregular visit scenarios with random censoring,
these percentages were 18%, 10%, 6% and 4%, and the corresponding expected
percentages of individuals censored were 16%, 11%, 8% and 5%. For each scenario,
we generated 1000 datasets, each with n = 1000 individuals. Estimation was done
with and without the constraint, which is true here, that ψk(k+m) = ψk′(k′+m).
Tables 1 and 2 show for the regular visit scenario without and with random
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censoring, respectively, the mean estimates and standard errors (SEs) for Methods
1–3. Results for the irregular visit scenario are in Web Appendix L. We see that
all the estimators are approximately unbiased, though there is some bias for ψ0(2),
ψ0(3) and ψ1(3), parameters for which there is relatively little information in the
data. Comparing SEs, we see that Methods 2 and 3 give very similar results, and
that these methods are more efficient than Method 1. This difference in efficiency
is much greater when there is random censoring (it is even greater when visit
times are irregular — see Web Appendix L). This may be because Method 1,
unlike 2 and 3, does not distinguish between failure and censoring (or occurrence
of next visit). Although Methods 2 and 3 use fitted values from the same GLM
that is used in Method 1, the estimating equations for Methods 2 and 3 involve
increments dN(t), which equal one only when a failure occurs. For Methods 1
and 2, coverage of 95% bootstrap confidence intervals (using 1000 bootstraps) was
close to 95% (see Table 3). Coverage was not evaluated for Method 3, as it is
computationally intensive to bootstrap this method for 1000 simulated datasets.
Imposing the constraint that ψk(k+m) = ψk′(k′+m) reduced SEs, as expected.
In this simulation study, censoring times are independent of exposures and con-
founders, and so censoring weights (Section 6) are not required for consistent
estimation of the ψk(l)’s. However, applying Method 1 with censoring weights
improved its efficiency (see Method 1cw in Tables 1 and 2), probably because
chance associations between exposures and censoring events are reduced in the
weighted sample. Coverage of bootstrap confidence intervals (Table 3) was close to
95% for most parameters, but there was overcoverage for some parameters. Using
censoring weights had no effect on the efficiency of Method 2.
Web Appendix L shows results for n = 250 or for a shorter follow-up time with
times between visits divided by four and administrative censoring at time 1 (and so
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fewer failures). These are qualitatively similar to the results in Tables 1 and 2, but
with the relative inefficiency of Method 1 being even more marked in the scenarios
with shorter follow-up time. Web Appendix L also describes a simulation study
that demonstrates the double robustness of Methods 2 and 3.
8. Analysis of Cystic Fibrosis registry data
The UK Cystic Fibrosis (CF) Registry records health data on nearly all people with
CF in the UK at designated approximately annual visits (Taylor-Robinson et al.,
2018). To illustrate the use of the SNCSTM, we used data on 2386 individuals
observed during 2008–2016 to investigate the causal effect of the drug DNase
on survival. DNase has been found to have a beneficial effect on lung function,
including using Registry data (Newsome S et al., 2019), but its effect on survival
has not been studied. Baseline visit was defined as an individual’s first visit during
2008–2015, and there were up to K = 8 follow-up visits. The (irregular) visit times
were defined as years after baseline visit; median time between visits was 1.00 years
(interquartile range 0.93 to 1.07). Individuals were defined as ‘treated’ if they had
used DNase since the previous visit and ‘untreated’ otherwise. Individuals treated
at a visit prior to their baseline visit were excluded, as were visits prior to age 18.
Administrative censoring was applied at the end of 2016 and non-administrative
censoring when an individual had a transplant or had not been seen for 18 months.
The percentage of treated patients increased from 14% at the baseline visit to
52% at visit 8, and most patients who began using DNase continued to use it.
There were 137 deaths during follow-up and 653 non-administrative censorings
(including 36 transplants). Of those who died, 74 (63) were treated (untreated) at
time of death. Total follow-up was 12380 person-years (py), and death rates while
treated and untreated were, respectively, 0.019 (74/3930) and 0.0075 (63/8450)
py−1. The ratio of the probabilities of surviving for one year while treated and
18 Biometrics, 000 0000
untreated is thus 0.981/0.9925 = 0.989. However, this may be due to confounding:
sicker patients being more likely to receive treatment.
We estimated the effect on survival of delaying initiation of treatment by one
year. To do this, we (re)defined Ak as Ak = 0 for those treated at visit k, and
Ak = 1 for those untreated. Now exp(−ψk(k)) represents the multiplicative causal
effect of intervening to start treatment at visit k rather than at visit k + 1 on
the probability of surviving for at least one year after visit k, among patients who







is the effect on the probability of surviving
at least m years after visit k if visits are exactly annual. We imposed the constraint
ψk(k+m) = ψk′(k′+m). (Potential) confounders at visit k were baseline variables
sex, age and genotype class (low, high, not assigned), and time-varying variables
FEV1%, body mass index, days of IV antibiotic use, and binary indicators for four
infections (P. aeruginosa, S. aureus, B. cepacia complex, Aspergillus), CF-related
diabetes, smoking, and use of other mucoactive treatments and oxygen therapy.
The same variables (and treatment) were included in models for inverse probability
of censoring weights.






from Method 2. These suggest
that starting treatment now rather than waiting may cause a small decrease in







0.996, 0.997, 0.994 and 0.988 form = 1, . . . , 5, respectively. However, the confidence
intervals (obtained by bootstrapping) include 1, i.e. no treatment effect. This lack
of a significant treatment effect may be because we have focused on a subset of
the population (adults not previously treated with DNase) and/or because there
are unmeasured confounders. As expected, Method 1 was very inefficient in this
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situation of irregular visits and substantial censoring. The confidence intervals were
between 4 and 9 times wider than those from Method 2.
For illustration, we also fitted a SNCSTM with an interaction between treatment
and FEV1%. Figures 1b–d shows the estimated ratios of survival probabilities for
three value of FEV1%: 40, 75 and 100 (the 10th, 50th and 90th centiles of the
distribution at baseline). Figure 1d suggests the ratio may actually be greater
than 1 for FEV1%= 100, i.e. starting treatment now may be better than waiting
for patients with high FEV1%. However, the interaction terms are not significant.
9. Discussion
One advantage of SNCSTMs is that, in contrast to MSMs, they can cope well with
situations where the inverse probabilities of exposure are highly variable. Indeed,
they can even be used when the so-called experimental treatment assignment
assumption is violated, i.e. when some individuals are, on the basis of their time-
varying covariate information, excluded from receiving particular exposure levels.
For these individuals, ∆i(t) = 0, meaning they do not contribute to the estimating
functions of Methods 1–3.
Another advantage of SNCSTMs is that they can be used to investigate time-
varying modification of exposure effects on survival time. Although it is, in princi-
ple, possible to do this using structural nested AFT models, estimation difficulties
caused by artificial recensoring mean that such models are usually kept simple and
interactions are not explored.
The SNCSTM can also be used to estimate the counterfactual exposure-free sur-




j=0 exp{Ajivj(t, Zji, S̄i)
⊤ψj}.
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vj(t, Zj , S̄)
⊤ψj}
]
. If there is censoring before time t, Ri(t) should be inversely
weighted by an estimate of P (Ci > t | Ā⌊t⌋i, L̄⌊t⌋i, S̄i).
A limitation is that, like other additive hazards models, the SNCSTM does not
constrain hazards to be non-negative, and so does not exclude survival probabilities
greater than one. Similarly, Picciotto et al.’s (2012) structural nested cumulative
failure time model does not exclude failure probabilities greater than one.
Method 1 appears to be less efficient than Methods 2 and 3, but has the attraction
that it can be applied using standard GLM software. In our simulation study,
the efficiency loss was fairly small when the only censoring was administrative
and visit times were regular. This method became much less competitive, how-
ever, when there was random censoring, and even more so when visit times were
irregular. By not distinguishing between failure and censoring, Method 1 may
also be more sensitive than Methods 2 and 3 to violation of the assumption that
λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) = λ(t, L0, S̄). Of the three, Method 3 gives consistent estimation
under the weakest assumptions. However, it needs more computation than Methods
1 and 2, especially when visit times are irregular and the exposure is binary. In
our simulation study, Methods 2 and 3 performed similarly, and so the theoretical
advantage of Method 3 may not be worth the extra computation. An R function
for implementing our methods, with examples, is described in Web Appendix I.
DMTV discuss the close connection between their model for a point exposure
(which is equivalent to the SNCSTM with K = 0) and Picciotto et al’s (2012)
cumulative failure time model. Although the latter is a discrete-time model for
the probability of failure, it is easy to finely discretise time so as to approximate
continuous time and (as Picciotto et al. note) to reformulate it as a model for
probability of survival. As DMTV explain, a drawback of Picciotto et al.’s method
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is the difficulty of deriving the efficient estimating equation. This difficulty arises
because their class of estimating functions uses correlated survival indicators. By
instead using independent increments of a counting process, DMTV were able to
derive the efficient estimating function. Methods 2 and 3 are extensions to time-
varying exposures of DMTV’s recommended method, and are therefore expected
also to be more efficient than Picciotto et al.’s method. In Web Appendix J we
elaborate on DMTV’s discussion of Picciotto et al.’s model and reformulate it
as a model for probability of survival. Tables 1 and 2 show mean estimates and
SEs for the resulting Picciotto et al. estimator (described in Web Appendix J and
denoted ‘Method P’ in tables). The SEs are larger than those of Methods 2 and 3,
suggesting Methods 2 and 3 are indeed more efficient. Methods 2 and 3 also have
the advantages of using closed-form estimators, handling random censoring auto-
matically (because estimating functions are framed in terms of increments, which
are observable up to the time of censoring), and being double robust. Picciotto et
al. use an iterative Nelder-Mead algorithm, employ inverse probability of censoring
weighting to handle random censoring, even when this censoring is completely at
random, and their estimator is not double robust.
In Web Appendix K we outline how the SNCSTM can handle competing risks.
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Figure 1: Estimates of the ratio of the survival probabilities when treatment is
initiated immediately compared to initiation being delayed by one year. a: from
the model with no interaction. b, c and d: from the model with interaction between
treatment and FEV1%.
1
Supporting Information for ‘Adjusting for Time-
Varying Confounders in Survival Analysis Using
Structural Nested Cumulative Survival Time Mod-
els’ by Seaman, Dukes, Keogh and Vansteelandt.
The proofs, estimators and inverse probability of censoring weights in these web
appendices are for the general SNCSTM described in Section 5 of the article.
Proofs, estimators and weights for the simple SNCSTM with regular visit times
and no effect modification are just special cases of the proofs, estimators and
weights given here. Specifically, for the simple SNCSTM, S̄ = (1, 2, . . . , K) and
Zk(l) = 1.
In these web appendices, we write vk(t)
⊤ψk as Gk(t). Mentions of equations (1)–(8)
refer to equations that appear in the article.
A. Proof of equation (3)
Model Ak implies we can write the probability density of Ak given Āk−1, L̄k, S̄, T >
Sk as
f(Ak | Āk−1, L̄k, S̄, T > Sk) = b(Ak;φk) exp{Akτ − c(τ)}/d(φ)
for some functions b(.), c(.) and d(.) and where τ = α⊤k0Hk is the linear predictor.
To simplify notation, we shall omit the explicit conditioning on S̄ and instead take
it as implicit.
Using Bayes’ Rule, Models Ak and Mk and the no-unmeasured confounders as-
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sumption, we have,
f(Ak | Āk−1, L̄k, T (Āk, 0) > t)
∝ f(Ak | Āk−1, L̄k, T (Āk, 0) > Sk)× P (T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk)
= f(Ak | Āk−1, L̄k, T > Sk)× P (T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk)
= b(Ak;φk) exp{Akτ − c(τ)}/d(φ)
×P (T (Āk−1, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk) exp{−AkGk(t)}
= b(Ak;φk) exp{Akτ − c(τ)}/d(φ)
×P (T (Āk−1, 0) > t | Āk−1, L̄k, T (Āk−1, 0) > Sk) exp{−AkGk(t)}






∗ − c(τ ∗)}/d(φ)
where τ ∗ = τ −Gk(t)d(φ).
B. Proof of equation (4)
First, we prove that










| Āk, L̄k, S̄, T > Sk
]
(9)
for t > Sk. To simplify notation, we shall omit the explicit conditioning on S̄ and
instead take it as implicit.
For t > Sk,
P{T (Āk−1, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk} exp{AkGk(t)}
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Hence, for Sk 6 t < Sk+1,
P{T (Āk−1, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk} (10)
= P{T > t | Āk, L̄k, T > Sk} exp{AkGk(t)}
= ET{R(t) | Āk, L̄k, T > Sk} exp{AkGk(t)}
= ET{R(t) exp{AkGk(t)} | Āk, L̄k, T > Sk} (11)
So, equation (9) has been proved for Sk 6 t < Sk+1.
Note that since (10) does not depend on Ak (by NUC), nor can (11). Hence, we
can also write:
P{T (Āk−1, 0) > t | Āk−1, L̄k, T (Āk−1, 0) > Sk} = E
{
R(t) exp{AkGk(t)} | Āk−1, L̄k, T > Sk
}
(12)
Next, for t > Sk+1,
P{T (Āk−1, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk} exp{AkGk(t)}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk} exp{AkGk(t)}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk+1}
×P{T (Āk, 0) > Sk+1 | Āk, L̄k, T (Āk, 0) > Sk} exp{AkGk(t)}
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Hence, for Sk+1 6 t < Sk+2,
P{T (Āk−1, 0) > t | Āk−1, L̄k, T (Āk−1, 0) > Sk}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk+1}
×P{T (Āk, 0) > Sk+1 | Āk, L̄k, T (Āk, 0) > Sk} exp{AkGk(t)}
= P{T (Āk, 0) > t | Āk, L̄k, T > Sk+1}
×P{T > Sk+1 | Āk, L̄k, T > Sk} exp{AkGk(t)}
= ELk+1 [P{T (Āk, 0) > t | Āk, L̄k+1, T > Sk+1} | Āk, L̄k, T > Sk+1]
×P{T > Sk+1 | Āk, L̄k, T > Sk} exp{AkGk(t)}
= ELk+1 [ET,Ak+1{R(t) exp{Ak+1Gk+1(t)} | Āk, L̄k+1, T > Sk+1} | Āk, L̄k, T > Sk+1]
×P{T > Sk+1 | Āk, L̄k, T > Sk} exp{AkGk(t)} (using (12))
= ET,Ak+1,Lk+1{R(t) exp{Ak+1Gk+1(t)} | Āk, L̄k, T > Sk+1}
×P{T > Sk+1 | Āk, L̄k, T > Sk} exp{AkGk(t)}
= ET,Ak+1,Lk+1{R(t) exp{AkGk(t) + Ak+1Gk+1(t)} | Āk, L̄k, T > Sk+1}
×P{T > Sk+1 | Āk, L̄k, T > Sk}
= ET,Ak+1,Lk+1{R(t) exp{AkGk(t) + Ak+1Gk+1(t)} | Āk, L̄k, T > Sk}
So, equation (9) has been proved for Sk+1 6 t < Sk+2.
Using induction, the same argument can be used to prove equation (9) for Sk+2 6
t < Sk+3, then for Sk+3 6 t < Sk+4, and so on.
5
Now, equation (4) follows from Mk and equation (9), because
P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk}
= P{T (Āk, 0) > t | Āk, L̄k, T (Āk−1, 0) > Sk}


























R(t)wk(t) | Āk, L̄k, T > Sk
}
Note that the no unmeasured confounders assumption means that the left-hand
side of equation (9) cannot depend onAk. Hence, the right-hand side cannot depend
on Ak either.
C. Relation between semiparametric efficient estimating equation for
ψk(k) and equation (6)
In their Section 3.1, DMTV derived the semiparametric efficient estimating equa-
tion for ψk(k) when the conditional distribution of Ak given (Āk−1, L̄k) and T > k is
known. This estimating equation involves inverse weighting by the hazard function.









dNi(t)− dΩki(t, Āki, L̄ki)− Akiψk(k) dt
}
= 0, (13)
where dΩk(t, Āk, L̄k) = E{dN(t)− Akψk(k) dt | Āk, L̄k, T > t} = E{dN(Āk−1,0)(t) |
Āk, L̄k, T (Āk−1, 0) > t} for t ∈ [k, k + 1). In their Section 4.1, DMTV showed
that if dΩk(t, Āk, L̄k) = γk(k)(t − k)
⊤Hk for all t ∈ [k, k + 1) for some (possibly)
time-varying parameter γk(k)(t − k) and if the term E(Ak | Āk−1, L̄k, T > t) in
∆k(t) = Ak − E(Ak | Āk−1, L̄k, T > t) is estimated by fitting a separate GLM at
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Ri(t)∆ki(t) dΩki(t, Āki, L̄ki) = 0, (14)
and so equation (13) reduces to equation (6). This result is also shown in our Web
Appendix F. In Web Appendix F, we further show that if E(Ak | Āk−1, L̄k, T >
t) is instead estimated by fitting a single GLM (as we do in Method 2), then
equation (14) still holds, provided that γk(k)(t− k) = γk(k) does not depend on t.
D. Estimation for the general SNCSTM
The following estimation methods, which are suitable for the general SNCSTM of
Section 5, generalise those described in Section 4. They reduce to those described
in Section 4 when visits times are regular with Sk = k and there is no effect
modification (i.e. Zk(l) = 1).
For the general SNCSTM of Section 5, which allows for irregular visit times, ∆k(t),
êk(l) and e
∗
k(l) depend, in general, on the visit times S̄, and Model Ak is the GLM




In Method 1, ψk(l) is estimated by ψ̂
M1
k(l) = −α̂k(l)/φk, where α̂k(l) is the estimate of
αk(l) given by fitting GLM














⊤ψj}. When visit times are regular, this set is the same as in Section 3.
Otherwise the rule for constructing the set is a little more complicated and is
7
given in Section D.4. Let êk(l)(Āk−1, L̄k, S̄, t) denote the fitted value of E(Ak |
Āk−1, L̄k, S̄, Q = t).
D.2 Method 2
In Method 2, ψk(l) (l > k) is estimated as the solution, ψ̂
M2
























where ∆k(t) is replaced by Ak − êk(l)(Āk−1, L̄k, S̄, t). Let Model Bk(l) (l > k) be de-




k(l)(Āk−1, L̄k, S̄, k)
ψ⊤k(l)Zk(l)
}
dt for all t ∈ [Sl, Sl+1).
As proved in Web Appendix F, estimator ψ̂M2k(l) is consistent under the conditions 1–
3 stated in Section 4.2 plus the extra condition that, unless all of Aj (j = k, . . . , l)
are correctly specified or Zk(l) = 1, additional covariates Z
int
k(l) ∗Hk are included in
each of the GLMs of equation (15). Here, X ∗ Y denotes all pairwise interactions
between X and Y .
When Ak is correctly specified, the true parameter values for these additional
covariates Z intk(l) ∗ Hk are zero and they can be omitted. In the analysis of the
Cystic Fibrosis registry data that allowed for an interaction between treatment
and FEV1%, described in Section 8, Z
int
k(l) ∗ Hk was omitted because its inclusion
caused instability in the estimates of ψ̂M2k(l).
When there is no effect modification or modification depends only on L0 (i.e.
Zk(l)’s depend at most on L0), stabilised weights can be used and Ajiψ
⊤
j(l)Zj(l),i




j(k) = Aj − E(Aj |
Āk−1, L̄k, S̄, Ti > Sj).
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D.3 Method 3
Modifying Method 3 is simple when visit times are regular: the GLM of Section 4.3




⊤Z intk(j). As with
Method 2, double robustness requires Z intk(l) ∗Hk be added as covariates.
D.4 General rule for construction of the set of pseudo-individuals
To estimate ψk(l), Methods 1 and 2 involve fitting a GLM for Ak given Āk−1, L̄k−1,
S̄ and Q to a set of pseudo-individuals. The rule for constructing this set when
the follow-up visit times are regular and equal to 1, 2, . . . , K was described in
Section 4.1 of the article. Here we describe the more general rule (of which that is
a special case), which can be used even when visit times are irregular.
For any t > 0, let Ik(l)(t) denote the set of individuals with T > Sk + t and
Sl 6 Sk + t < Sl+1, i.e. those who t units after their kth visit are still at risk and
have had their lth visit but not yet their (l + 1)th visit. Let qmink(l) and q
max
k(l) denote,
respectively, the minimum and maximum values of t such that the set Ik(l)(t) is not

















k(l))/9, . . . , q
max
k(l) ),
take the set Ik(l)(t) and for each individual i in this set, create a pseudo-individual
with Q = Ski+t and the same value of (ĀK , L̄K , S̄) as individual i. Let Pk(l) denote
the resulting set of (up to 10n) pseudo-individuals.
Note that in the special case of regular visit times, qmink(l) = Sl − Sk and q
max
k(l) =
Sl+1−Sk (assuming there are still individuals at risk at time Sl+1). Therefore, each
pseudo-individual has a value of Q equal to one of Sl, Sl + (Sl+1 −Sl)/9, . . ., Sl+1.
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E. Closed form of estimator for Methods 2 and 3
E.1 Method 2







































































Note that the term Ak − g
−1
(




in equation (18) is just ∆k(t). This is because it follows from equation (3) of the
article that
∆k(t) = Ak − E{Ak | Āk−1, L̄k, S̄, T (Āk, 0) > t}
= Ak − g
−1
(
g[E{Ak | Āk−1, L̄k, S̄, T (Āk, 0) > t}]
)
















= Ak − g
−1
{
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k(l)Zk(l) if l > k
0 if l = k
E = g{E(Ak | Āk−1, L̄k, S̄, T (Āk, 0) > Sl)}
D = α⊤k(l)Zk(l)
When g is the identify link function, expression (19) becomes
∫ y
0











B−1 exp(By){∆k(Sl)−Dy} − B
−1∆k(Sl) +B
−2D{exp(By)− 1} if B 6= 0
∆k(Sl)y −Dy
2/2 if B = 0




























dt if B = 0
where F = B +D.










1 + exp(E +Dt)
dt
= D−1 [log{1 + exp(E +Dy)} − log{1 + exp(E)}]
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1 + exp(E +Dt)
dt
= y exp(E)− exp(E)D−1 [log{1 + exp(E +Dy)} − log{1 + exp(E)}]


















When F 6= 0 and D 6= 0, numerical integration can be used.
E.2 Method 3


































and rewrite wk(Sl + t) for l > k and t ∈ [0, Sl+1 − Sl) as


















with wk(Sk + t) = 1 and t ∈ [0, Sk+1 − Sk).
In Method 3, we fit a separate model for E(Aki | Āk−1,i, L̄ki, S̄i, T (Āki, 0) > Ski+ t)
for each value t at which the set Ik(t) (defined in Web Appendix D.4) changes.
Henceforth we assume that visit times are regular. Then the set Ik(t) changes
when one of the individuals fails, is censored or has their (l+1)th exposure at time
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Sk + t, i.e. when T ∧ Sl+1 = Sk + t. Let e0 = 0 and let {e1, . . . , eQkl} denote the
set of distinct values of (Ti ∧ Sl+1)− Sl that are greater than or equal to zero. So,
the fitted value of E(Aki | Āk−1,i, L̄ki, S̄i, T (Āki, 0) > Sl + t) used for ∆ki(Sl + t)
in equation (20) is constant over each interval t ∈ [eq, eq+1) (q = 0, . . . , Qkl − 1).
Consequently, we can write, for l = k,
∫ Sl+1−Sl
0





R(Sl + eq) ∆k(Sl + eq)(eq+1 − eq)
and for k > l,
∫ Sl+1−Sl
0














































































































R(Sl + eq) ∆k(Sl + eq)(eq+1 − eq)
F. Proof of double robustness of Methods 2 and 3
The basic results that justify Methods 2 and 3 are equation (9) and
















R(t)wk(t) | Āk, L̄k, S̄, T > Sk
} (22)
for l > k and t ∈ [Sl, Sl+1). We show below that equation (22) is implied by
equation (9) and Models Mk, . . . ,Ml. Equation (22) means that within a stratum
of the population defined by (Āk, L̄k, S̄) and by T (Āk−1, 0) > Sk (or equivalently,





j(l)Zj(l) after weighting individuals by wk(t). Note
that, since the left-hand side of equation (22) does not depend on Ak (because of
the no unmeasured confounders assumption), neither can the right-hand side.
We now prove equation (22). Again, we omit the explicit conditioning on S̄. By
taking logs of both sides of equation (9) and differentiating with respect to t and
multiplying both sides by minus one, we obtain





















| Āk, L̄k, T > Sk
)
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It follows from this and equation (9) that
E{dN(Āk−1,0)(t) | Āk, L̄k, T (Āk−1, 0) > t}
=
E{dN(Āk−1,0)(t) | Āk, L̄k, T (Āk−1, 0) > Sk}








































































R(t)wk(t) | Āk, L̄k, T > Sk
}











j(l)Zj(l). Hence, equation (22)
holds.
We now use this result to prove consistency of estimation for Method 2. Suppose
that ψj(m) (k < j 6 m 6 l) have already been consistently estimated by Method
2 and we are now estimating ψk(l). Assume that Models Mk, . . . ,Ml are correctly
specified.














This is the same as the estimating function we use — i.e. the ith element of the left-
hand side of equation (7) — (apart from the Zk(l) term) but with ∆k(Sl) replaced
by Ak.













| Āk, L̄k, T > Sk
]
= ∆k(t)E{dN(Āk−1,0)(t) | Āk, L̄k, T (Āk−1, 0) > t} ×E{R(t)wk(t) | Āk, L̄k, T > Sk}
= ∆k(t)E{dN(Āk−1,0)(t) | Āk−1, L̄k, T (Āk−1, 0) > t} × E{R(t)wk(t) | Āk, L̄k, T > Sk}
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| Āk−1, L̄k, T > Sk
]
= E{dN(Āk−1,0)(t) | Āk−1, L̄k, T (Āk−1, 0) > t} (24)
×E[∆k(t)E{R(t)wk(t) | Āk, L̄k, T > Sk} | Āk−1, L̄k, T > Sk]
= E{dN(Āk−1,0)(t) | Āk−1, L̄k, T (Āk−1, 0) > t}
×E[∆k(t)P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk} | Āk−1, L̄k, T > Sk]
(25)
Line (25) follows from equation (4).
If Ak is correctly specified,
E
[
∆k(t)P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk} | Āk−1, L̄k, T > Sk
]
≡ E[{Ak − E(Ak | Āk−1, L̄k, T (Āk, 0) > t)}
×P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk} | Āk−1, L̄k, T > Sk]
= P{T (Āk, 0) > t | Āk−1, L̄k, T (Āk, 0) > Sk}
×{E(Ak | Āk−1, L̄k, T (Āk, 0) > t)− E(Ak | Āk−1, L̄k, T (Āk, 0) > t)}(26)
= 0 (27)
Equation (26) follows because, for a general random variable X and a general event
A, E{X P (A | X)} = P (A)E(X | A). In conclusion, we have shown that equa-
tion (23) has expectation zero. Now, if we replace Ak in equation (23) by ∆i(Sl),
then we are simply adding a function of (Āk−1, L̄k) multiplied by R(t)wk(t)∆k(t).
It is straightforward to show that this extra term has expectation zero when Ak is
16 Biometrics, 000 0000
correctly specified. This is because
E{R(t)wk(t)∆k(t) | Āk, L̄k, T (Āk, 0) > Sk}
= ∆k(t) E{R(t)wk(t) | Āk, L̄k, T (Āk, 0) > Sk}
= ∆k(t) P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk}
using equation (4). Now, taking the conditional expectation of this over Ak given
(Ak−1, L̄k) and T (Āk, 0) > Sk, we obtain
E{R(t)wk(t)∆k(t) | Āk−1, L̄k, T (Āk, 0) > Sk}
= E
[
∆k(t)P{T (Āk, 0) > t | Āk, L̄k, T (Āk, 0) > Sk} | Āk−1, L̄k, T > Sk
]
,
which we know, from equation (27), equals zero.
Likewise, when the Zk(l)’s are functions only of L0, changing Aj to ∆
†
j(k) = Aj −
E†(Aj | Āk−1, L̄k, S̄, T > Sk) (j = k + 1, . . . , l) in the estimating function (23),
where E†(Aj | Āk−1, L̄k, S̄, T > Sk) denotes the limiting fitted value from Model
Cj(k), simply adds a function of (Āk−1, L̄k) multiplied by R(t)wk(t)∆k(t), and so
the same is true. Finally, if the Zk(l)’s are functions only of L0 and we replace wk(t)
by w∗k(t), we are simply multiplying the estimating function (23) by a function of
(Āk−1, L̄k), and so it still has conditional expectation zero given (Āk−1, L̄k) and
T (Āk, 0) > Sk.
Now suppose that Ak may not be correctly specified but Bk(l) is correctly specified.

























for any given value of γk(l), and with ∆k(t) replaced by its estimate obtained
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as described in Section 4.2 of the article. These are the same as the estimating
equations we use (i.e. equation (16)) except that they include the extra term
γ⊤k(l)Hk.
























E{dN(Āk−1,0)(t) | Āk, L̄k, T (Āk−1, 0) > t} − γ
⊤
k(l) hk(Āk−1, L̄k, S̄)




×E{R(t)wk(t) | Āk, L̄k, T (Āk−1, 0) > Sk} ×∆k(t)
which equals zero when Model Bk(l) holds. Hence, equations (28) are unbiased
estimating equations for ψk(l) when Bk(l) is correctly specified and γk(l) equals its
true value.
Finally, we shall show that, when either Zk(l) = 1 or Z
int
k(l) ∗ Hk is included in
GLM (15), then, because of the way that E(Aki | Āk−1,i, L̄ki, Ti(Āk, 0) > t) in









k(l)Hk dt = 0 (29)
for any value of γk(l), regardless of whether Model Ak or Model Bk(l) is correctly
specified. This means that equations (28) reduce to equations (16), and thus our
estimating equations (16) have expectation zero when either Model Ak or Model
Bk(l) is correctly specified.
The reason why equation (29) holds is as follows. Let X denote any element of the
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I(Sli 6 Ski + t < Sk+1,i)





























I(Sli 6 Ski + t < Sk+1,i)






Expression (30) equals zero because it is one element of the score function vector
(multiplied by (qmaxk(l) − q
min
k(l) )/9) for the GLM of equation (15) fitted to the set Pk(l)
with weights wk(Q). (The set Pk(l) was defined in Web Appendix D.4.)
The proof of double robustness of Method 3 is similar. The difference lies in the way
that fitted values of E(Aki | Āk−1,i, L̄ki, S̄i, Ti(Āki, 0) > t) are estimated. Suppose
for simplicity that Zk(l) = 1 and visit times are regular. For Method 3, the score
equations corresponding to GLM g{E(Ak | Āk−1, L̄k} = αk0(t)
⊤Hk fitted to Ik(t)




Ri(Ski + t)I(Sl 6 Sk + t < Sl+1)wki(Sk + t)∆ki(Sk + t)Hki = 0 (31)
(The set Ik(t) was defined in Web Appendix D.4.) Hence, equation (31) holds for
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Ri(Ski + t)I(Sl 6 Sk + t < Sl+1)wki(Sk + t) ∆ki(Sk + t)
×γk(l)(t+ Sk − Sl)
⊤Hki dt







Ri(Ski + t)I(Sl 6 Sk + t < Sl+1)
×wki(Sk + t) ∆ki(Sk + t)Hki dt
= 0.
G. Constraining exposure effects
In this web appendix we explain how estimation of parameters can be performed
under the constraint that ψk(k+m) = ψk′(k′+m) for all k, k
′, m.
For Method 1, a simple way to estimate ψk(k+m) under this constraint is to calculate
ψ̂M1k(k+m) (k = 0, . . . , K −m) separately as before and then, for each element of the
vector ψ̂M1k(k+m), calculate a weighted average of these K−m+1 estimates. Suitable
weights are the reciprocals of the corresponding K − m + 1 variances estimated
using a sandwich variance estimator that accounts for duplication of individuals
as pseudo-individuals. It can be calculated using standard software and is a valid
estimator of the variance of ψ̂M1k(k), but not of ψ̂
M1
k(k+m) when m > 0, because it
ignores the uncertainty in wk(t) arising from estimating the ψ’s. Nonetheless, it
suffices for the purpose of averaging the K − m + 1 estimates of ψk(k+m). For
Methods 2 and 3, we simply sum the K − m + 1 estimating equations (7) for
ψk(k+m) (k = 0, . . . , K −m) and solve the resulting single equation.
In Section 3, we assumed the regular visit times are 0, 1, . . . , K, rescaling the time
variable if necessary. Such rescaling may make it more reasonable to constrain
20 Biometrics, 000 0000
ψk(k+m) to be a known multiple of ψk′(k′+m). For example, if visits 1 and 2 are one
and 13 months, respectively, after baseline, then ψ0(0) and ψ1(1) are measured in
units of per-month and per-year, respectively. Since ψ0(0) and ψ1(1)/12 are measured
in the same units (per-month), one might constrain ψ0(0) = ψ1(1)/12. This requires
only minor modification of the above procedures. However, using the more general
SNCSTM described in Section 5 avoids the need to rescale time.
We have only considered one form of constraint on the exposure effects; Vanstee-
landt and Sjolander (2016) show how to impose other forms.
H. Inverse probability of censoring weighting
Assume that the first condition in Section 6 holds, namely, that
E{dNC(t) | C > t, Ā⌊T̃ ⌋, L̄⌊T̃ ⌋, S̄, T̃ > t, T̃} = λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄). (32)




λ(s, Ā⌊s⌋, L̄⌊s⌋, S̄) ds
}
. This is the inverse probability of re-
maining uncensored at time t. A parametric model for λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) is specified
and its parameters (and hence wCk (t)) are estimated from the data. Now Methods
1–3 can be used with the weights wk(t) replaced by wk(t)×w
C
k (t). If the assumptions
sufficient for consistency in the absence of censoring (see Section 4) are satisfied,
and equation (32) holds, and the model for λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) is correctly specified,
then the resulting estimates of ψk(l) are consistent.
More stable weights can be obtained by specifying, for each k = 0, . . . , K, an addi-
tional parametric model for λk(s, Āk−1, L̄k, S̄) = E{dNC(t) | C > t, Āk−1, L̄k, S̄, T̃ >
t} (t > Sk). This differs from the previous model in that it is conditional only
on (Āk−1, L̄k). After estimating the parameters of this model, w
C
k (t) is replaced




λ(s, Ā⌊s⌋, L̄⌊s⌋, S̄) ds −
∫ t
Sk
λk(s, Āk−1, L̄k, S̄) ds
}
. Note that
misspecification of this additional model does not affect consistency of the estima-
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tor of ψk(l), and that if λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) = λ(t, Āk−1, L̄k, S̄) for all t ∈ [Sk, Sl+1),
then wCSk (t) = 1 for t ∈ [Sk, Sl+1), i.e. no censoring weights are needed when
estimating ψk(l).
The formulae given in Web Appendix E for Method 2 are easily extended to handle
inverse probability of censoring weighting, provided that the parametric models for
censoring are proportional hazards models with a constant baseline hazard between
visits. We now explain how this is done.
Above, we referred to two parametric models, one for λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) and an
additional one for λk(t, Āk−1, L̄k, S̄), and said that the stabilised inverse probability





λ(s, Ā⌊s⌋,i, L̄⌊s⌋,i, S̄i) ds−
∫ t
Ski
λk(s, Āk−1,i, L̄ki, S̄i) ds
}
.
(If unstabilised weights are used, λk(s, Āk−1, L̄k, S̄) is simply replaced by zero.)
For the first parametric model, we assume
λ(t, Ā⌊t⌋, L̄⌊t⌋, S̄) = exp{β
⊤
k bk(Āk, L̄k, S̄)}
for t ∈ [Sk, Sk+1), where bk(Āk, L̄k, S̄) is a known vector function of (Āk, L̄k, S̄)
whose first element equals one (this is an intercept term), and βk is an unknown
vector parameter. For the second parametric model, we assume
λk(t, Āk−1, L̄k, S̄) = exp{β
⊤
k(l) bk(l)(Āk−1, L̄k, S̄)}
for t ∈ [Sl, Sl+1), where bk(l)(Āk−1, L̄k, S̄) is a known vector function of (Āk−1, L̄k, S̄)
whose first element equals one, and βk(l) is an unknown vector parameter. Abbre-
viate bk(Āk, L̄k, S̄) as bk and bk(l)(Āk−1, L̄k, S̄) as bk(l). The inverse probability of

































× (Sj+1 − Sj)
}
.
So, in equation (18), we should replace wk(T ) by wk(T )×w
CS
k(l)(T ), replace wk(Sl)
by wk(Sl)× w
CS
















Similar modifications can be made to Method 3.
I. Software
Our R function sncstm can be used to apply Methods 1–3. Note that Method 3
is only implemented for regular visits and without inverse probability of censoring
weights.
Two examples of the use of sncstm are provided in the files ‘example1.r’ and
‘example2.r’.
The compulsory arguments of sncstm are as follows:
data : A data frame containing the following elements (here n is the number of
individuals, K +1 is the number of visits, and p is the number of variables that
are confounders in at least one of Models A0, . . . ,AK):
• tim — n-vector containing the failure or censoring time for each individual
• fail — n-vector containing the failure/censoring indicator for each individual
(equals TRUE if fails and FALSE if censored)
• tau — n× (K + 1) matrix whose (i, k+ 1)th entry is Ski, the kth visit time
for individual i (note that all the entries in the first column should equal
zero, because S0i = 0)
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• A — n × (K + 1) matrix whose ith row equals (A0i, A1i, . . . , AKi), the
treatments for individual i
• L — n× p matrix whose ith row contains the values for individual i of the
p variables that are confounders in at least one of Models A0, . . . ,AK
• Z (optional) — if the optional argument useZ (see below) is not specified,
then Z should not be specified either, but if useZ is specified, then Z should
be a matrix; see Example 2 for details of how to specify Z when useZ is
specified
useA : (K+1)×(K+1) matrix whose (k+1)th row indicates which of A0, A1, . . . , Ak−1
to include as covariates in Model Ak. If the (k+1, j+1)th element of useA equals
TRUE, Aj is included in Ak. If this element of useA equals FALSE, Aj is not
included.
useL : (K+1)×p matrix whose (k+1)th row indicates which of the p confounders
to include as covariates in Model Ak. If the (k + 1, j + 1)th element of useL
equals TRUE, the jth of the p confounders is included in Ak. If this element of
useL equals FALSE, the jth confounder is not included.
EXPOSETYPE : ‘gaussian’ if Model Ak is a linear regression; ‘binomial’ if Ak is a
logistic regression.
The optional arguments of the sncstm function are as follows (‘by default’ means
if the argument is not specified):
METHOD : Indicates which of the three estimation methods described in our article
should be used to estimate the ψk(l) parameters. By default, this equals 2,
meaning that Method 2 is used. To use one of the other methods, set METHOD
equal to 1 or 3.
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CONSTRAIN : By default, this equals FALSE. If it equals TRUE, the constraint
that ψk(k+m) = ψk′(k′+m) for all k, k
′, m is imposed.
NQUAD : When visit times are regular, this is the number of equally spaced values
of t between Sk and Sk+1 at which a pseudo-individual is created from each
individual still at risk. When visit times are irregular, it is the number of equally
spaced values of t between qmink(l) and q
max
k(l) (see Web Appendix D.4). By default,
this equals 10, which is the number used for the main simulation study reported
in our article. If the probability of failure between consecutive visits is large (e.g.
> 10% of individuals still at risk at visit k fail before visit k + 1) or if visit
times are highly irregular (so that qmaxk(l) − q
min
k(l) is very large), it may be desirable
to increase NQUAD. The aim should be to choose NQUAD to be large enough
such that any further increase in NQUAD has little impact on the estimates of
ψk(l). The NQUAD argument is ignored if METHOD=3.
STABILISE : By default, this equals FALSE, meaning that unstabilised weights
wk(t) are used. When useZ (see below) is not specified (so that the SNCSTM
assumes there is no effect modification), STABILISE can be set equal to TRUE,
meaning that stabilised weights w∗k(t) are used instead of wk(t).
IPCW : By default, this equals FALSE, meaning there is no inverse probability of
censoring weighting. Specify IPCW=TRUE to use inverse probability of censor-
ing weighting.
useAcensor : If IPCW=TRUE, useAcensor is a (K + 1) × (K + 1) matrix, whose
(k+1, j+1)th entry equals TRUE if Aj is included in the model for the hazard of
censoring during time interval [Sk, Sk+1), and equals FALSE if it is not included.
Ignored if IPCW=FALSE.
useLcensor : If IPCW=TRUE, useLcensor is a (K + 1) × p matrix, whose (k +
1, j + 1)th entry equals TRUE if the jth variable in the L component of the
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data frame called ‘data’ (see above) is included in the model for the hazard of
censoring during time interval [Sk, Sk+1), and equals FALSE if this variable is
not included. Ignored if IPCW=FALSE.
admincens : The censoring model (i.e. the model used to calculate the inverse
probability of censoring weights) considers censoring as the ‘event’ of interest
and considers failure as a ‘censoring’. By default, the censoring model treats
all censorings as ‘events’. However, one might not want inverse probability of
censoring weights to adjust for administrative censorings. If so, adminstrative
censorings need to be treated as ‘censorings’ rather than ‘events’ in the censoring
model. To treat some censorings as ‘censorings’ rather than ‘events’ in the
censoring model, specify admincens as a vector of length n whose ith entry
equals TRUE if the censoring of individual i is to be treated by the censoring
model as a ‘censoring’ and equals FALSE if it is to be treated as an ‘event’. This
argument is ignored if IPCW is not specified or if IPCW is specified to equal
FALSE.
useZ : By default, there is assumed to be no effect modification, i.e. it assumes that
the causal effect of Ak does not depend on the treatment or confounder histories
(Āk−1, L̄k). This assumption corresponds to Zk(l) = 1 in the SNCSTM. useZ can
be used to indicate that the SNCSTM should instead allow the causal effect of
Ak to depend on (Āk−1, L̄k). In that case, useZ should be a (K +1)× (K +1)×
(Nmod + 1) array, where Nmod is the number of effect modifiers of Ak. Note that
if useZ is specified, its (k, l, 1)th entry should equal 1 for all k and l (so that a
main effect of Ak is included in the SNCSTM) and the Z component of the data
frame called ‘data’ (see above) should also be specified. See Example 2 for an
example of how to specify useZ and Z.
RETURNBOOT : By default, this equals FALSE. To use the sncstm function
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with the boot function, in order to calculate bootstrap confidence intervals, set
RETURNBOOT equal to TRUE. See Examples 1 and 2 for how to use the boot
function.
EXPONCUM : By default, this equals FALSE. If it equals TRUE, the sncstm
function returns not only the estimates of ψk(l) (0 6 k 6 l 6 K) but also the
corresponding estimates of
∑l






are relevant to the calculation of relative probabilities of survival (see the analysis
of the Cystic Fibrosis data in Section 8 of our article).
VERBOSE : By default, this equals FALSE. If it equals TRUE, the sncstm function
will print some extra information.
J. Comparison with Picciotto et al.’s (2012) method
J.1 The case of K = 0
For simplicity, suppose that K = 0, that Z0(0) = 1 (i.e. no effect modification),
that there is no random censoring, and that all individuals still at risk at time 10
are administratively censored at that time.
To compare the SNCSTM with Picciotto et al.’s (2012) method, first reformulate
Picciotto et al.’s original structural nested cumulative failure time model as a
model for survival, rather than failure. Then treat the data as being the result of
ten visits, at times t = 0, . . . , 9, at each of which the exposure of an individual
is the same (i.e. A0), with the exposure effect being ψ0(0). Then Picciotto et al.’s
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where Ās0 = A0 if s > 0 and is null otherwise, and where J(Ā
s
0, L0, t) andB(Ā
s
0, L0, t)
are any given functions of Ās0, L0 and t. Picciotto et al. use J(Ā
s
0, L0, t) = 1 and
B(Ās0, L0, t) = 0. Obviously, Ê(A0 | Ā
s
0, L0, T > s) = A0 when s > 0. So, with
B(Ās0, L0, t) = 0, expression (33) reduces to




J(L0, t) exp(ψ0(0)A0t)R(t) (34)
As Dukes and Vansteelandt (2018) explain, a drawback of Picciotto et al.’s method
relative to Methods 2 and 3 is the difficulty of deriving the efficient choice of
J(L0, t). This difficulty arises because of the correlation between the survival indica-
tors R(1), . . . , R(10). Methods 2 and 3 are instead based on independent martingale
increments, which makes it easier to derive efficient estimating equations.
J.2 The case of K = 1
Now consider the more complicated scenario where K = 1. Suppose that we still
have Z0(0) = Z0(1) = Z1(1) = 1 (i.e. no effect modification) and still there is no
random censoring. Suppose that S1 = 10, i.e. A1 is measured at time 10 and that
all individuals still at risk at time 20 are administratively censored at that time
(S2 = 20).
Picciotto et al.’s estimating function for (ψ0(0), ψ1(1), ψ0(1)) is (using their notation
28 Biometrics, 000 0000






{A0 − Ê(A0 | Ā
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s







J(As0, L0, t)I(s 6 9) + J(Ā
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where Ās1 = A0 for s 6 10 and Ā
s
1 = Ā1 for s > 11. If we take J(L0, t) = J0(0) for
t 6 10, J(L0, t) = J0(1) for t > 11 and J(A0, L̄1, t) = J1(1), then this becomes























exp{(ψ0(1)A0 + ψ1(1)A1)(t− 10)}R(t)





If we choose J0(0) = (1, 0, 0)
⊤, J1(1) = (0, 1, 0)
⊤ and J0(1) = (0, 0, 1)
⊤, then this
estimating function becomes a vector with the following three elements:









exp{(A0ψ0(1) + A1ψ1(1))(t− 10)}R(t)





To impose the constraint that ψ0(0) = ψ1(1), one may instead choose J0(0) = J1(1) =
(1, 0)⊤ and J0(1) = (0, 1)
⊤.
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J.3 The general case of K > 0
More generally, for K > 0, the estimating function is a vector with elements of the
form






















R(t) (0 6 k 6 l 6 K)
when the constraint ψk(k+m) = ψk′(k′+m) ∀k, k
′, m is not imposed, and analogously
when the constraint is imposed.
J.4 Structural nested cumulative failure time model with censoring
When there is random (i.e. non-administrative) censoring, Picciotto et al. (2012)
use inverse probability of censoring weights for their structural nested cumulative
failure time model. These weights involve the conditional probability that an
individual is censored by time t + 1 given that he or she has survived and not
been censored by time t and his or her treatment and confounder histories at time
t. Note that this probability will, in general, depend on the treatment history at
time t, even if censoring is completely at random, because individuals cease to be
at risk of censoring when they fail. For example, suppose that K = 0, that there
are no baseline confounders L0 and that treatment A0 increases the hazard of
failure between times 0 and 1. Then the expected time that an individual is at risk
of being censored is less for a treated individual than for an untreated individual.
Suppose censoring is completely at random. Then the probability of being censored
by time 1 is lower for treated individuals than for untreated individuals, because
of the former group’s smaller expected time at risk of censoring. For readers who
are interested, we now provide a more specific example.
Let A0 be binary with P (A0 = 1) = 0.5 and let T (a0) ∼ exp(0.5+0.5a0) (a0 = 0, 1)
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independently of A0. The true value of ψ0(0) is given by
ψ0(0) = log
[
P{T < 1 | A0 = 1}




P{T (1) < 1}








Picciotto et al.’s estimating function (see their first equation after their equation
(11)) is
{A0 − E(A0)} exp(−ψ0(0)A0)I(T 6 1) (35)
when there is no censoring. Expression (35) can be shown to have expectation zero
when ψ0(0) = 0.474.
Now suppose there is censoring, with C denoting an individual’s censoring time.
Picciotto et al. replace the term I(T 6 1) in expression (35) by I(T 6 1, C > T )
(see their Section 6) and their estimating function becomes
{A0 − E(A0)} exp(−ψ0(0)A0)I(T 6 1, C > T ) (36)
This equals −0.5×I{T (0) 6 1, C > T (0)} if A0 = 0 and 0.5 exp(−ψ0(0))×I{T (1) 6
1, C > T (1)} if A0 = 1.
Suppose that C ∼ exp(5) independently of A0, T (0) and T (1). Then































This equals zero when









So, the estimator of ψ0(0) will converge asymptotically to 0.608, rather than to the
true value, 0.474.
This (asymptotic) bias can be corrected by using inverse probability of censoring
weighting. The weight for an individual with A0 = a0 is 1/P{C > T (a0)} =
exp{5 T (a0)}. So, the weighted estimating function is
{A0 − E(A0)} exp(−ψ0(0)A0)I(T 6 1, C > T )× exp(5T ) (38)
To calculate the expectation of expression (38) at various values of ψ0(0), we
simulated data on A0, T and C for 10
7 individuals, calculated expression (38) for
each individual, and averaged over the individuals. Figure 2 shows the result. Also
shown in Figure 2 is the expectation of the unweighted estimating function. (This
latter expectation is given by expression (37), but we also verified that the same
result was obtained by calculating expression (36) for each of the 107 simulated
individuals and averaging.) We see from Figure 2 that, unlike the unweighted
estimating function, the weighted estimating function has expectation zero at
ψ0(0) = 0.476. This is very close to the true value of ψ0(0), viz. 0.474. The very
small difference is likely to be due to the Monte Carlo error inherent in calculating
the expectation by simulation.
J.5 Censoring for the structural nested model for survival
Now consider our situation, where Picciotto et al.’s structural nested cumulative
failure time model has been reformulated as a model for survival, rather than
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for failure. In this reformulated model, no inverse probability of weighting is re-
quired when censoring is completely at random. We now explain why this is.
Consider the estimating function of expression (34). The quantity {A0 − Ê(A0 |
L0)}J(L0, t) exp(ψ0(0)A0t)R(t) is unknown if R(t), the survival status at time t, is
unknown. If we exclude individuals whose R(t) is unknown, we should compensate
for this exclusion by weighting each individual whose R(t) is known by the inverse
of the probability that his or her R(t) is known. R(t) is known if T < C or C > t.
So, if censoring is completely at random, with cumulative hazard H(t), then the
probability that R(t) is known is exp{−H(t ∧ T )}. In fact, this probability needs
to be evaluated only for those individuals whose R(t) is known and equals 1. This
is because {A0 − Ê(A0 | L0)}J(L0, t) exp(ψ0(0)A0t)R(t) = 0 when R(t) = 0. For
an individual whose R(t) is known to equal 1, T must be greater than t, meaning
that exp{−H(t∧T )} = exp{−H(t)}. Since exp{−H(t)} is a constant (apart from
depending on t), there is no need to weight by its inverse.
J.6 Applying Picciotto et al.’s estimation method in simulation study
We compared the performance of Picciotto et al.’s estimation method to our
Methods 1–3 in the two regular visit scenarios of the simulation study of Section 7
of our article. In this simulation study, S1 = 1, S2 = 2, etc., rather than S1 = 10,
S = 20, etc. as was assumed above. So, the estimating equations become









exp{(A0ψ0(1) + A1ψ1(1))(t− 10)/10}R(t/10) = 0




exp{A1ψ1(1)(t− 10)/10}R(t/10) = 0
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etc., when the constraint ψk(k+m) = ψk′(k′+m) ∀k, k
′, m is not imposed, and analo-
gously when the constraint is imposed. Inverse probability of censoring weighting
was used in the scenario with random censoring, as described in Web Appendix J.4.
As Picciotto et al. (2012) note, these estimating equations cannot be solved using
the Newton-Raphson algorithm. They used the Newson-Mead algorithm; we used
a simple grid search with a fine grid.
Results are reported in Section 7 and Tables 1 and 2 of our article.
K. Competing risks
Suppose there are two competing causes of failure. Let T (Āk, 0) be the counter-
factual failure time as previously defined, that is, it is the time from the start of




counterfactual counting process indicator for a failure due to cause j (j = 1, 2).


















for t ∈ [l, l + 1) and j = 1, 2. Building on similar results in Martinussen and
Vansteelandt (2018), the procedure proposed in our article is readily adjusted to
the estimation of ψ
(j)














This change accounts for the fact that the conditional mean of the at-risk indicator
R(t) = I(T > t) is influenced by the cause-specific hazards of both failure types.
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which must be solved jointly for j = 1 and j = 2.
Formulae very similar to those given by Martinussen and Vansteelandt (2018) can
be used to convert these estimates of the parameters ψ
(j)
k(l), which describe the causal
effect of exposure on cause-specific hazards, into estimates of the causal effect of
exposure on cumulative incidence.
L. Additional simulation studies
In Section 7 we showed results for n = 1000 in the two regular visit scenarios, one
with no censoring and one with random censoring. Web Tables 4 and 5 show the
results for the irregular visit scenario.
Web Tables 6–11 show the corresponding results for the three scenarios when n =
250.
Web Tables 12–17 show the corresponding results for n = 1000 with a shorter
follow-up time. In this case, the visit times are divided by four and administrative
censoring occurs at time 1. This means that the visit times are Sk = k/4 (k =
0, . . . , 4) in the regular visit scenarios and the inter-visit times are Sk − Sk−1 ∼
Uniform[0.5/4, 1.5/4] in the irregular visit scenario.
We also carried out a simple simulation study to illustrate the double robustness
properties of Methods 2 and 3. We shall use B∗k(l) to denote the modified version
of Model Bk(l) allowed by Method 3. The original model, Model Bk(l), allowed by
Method 2 assumes that the intercept and coefficients for Āk−1 and L̄k are constant
over time. The modified model, Model B∗k(l), is more general, allowing as it does
the intercept and coefficients for Āk−1 and L̄k to vary over time. If Model Bk(l) is
correctly specified, then so is Model B∗k(l).
In this simulation study, we assumed K = 1, S0 = 0, S1 = 1, a single time-
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dependent, continuous confounder, and a continuous treatment. The hazard of
T (a0, 0) given A0 and L0 during time interval t ∈ [0, 1) was assumed to be
E{dN(a0,0)(t) | A0, L0, T (a0, 0) > t} = ω0 + γ00L0 + δ00a0 t ∈ [0, 1)
where ω0 = 2.7, γ00 = 0.75 and δ00 = −0.3. This implies that Model M0 is
correctly specified during the time interval t ∈ [0, 1) and ψ0(0) = δ00 = −0.3. It also
implies that Model B0(0) is correctly specified, since E{dN(0)(t) | A0, L0, T (0) >
t} = ω0 + γ00L0 is linear in L0 and the intercept ω0 and coefficient γ00 of L0 are
constant in t.
Intervening on A0 may change the value of L1. So, let L1(a0) denote the value of
L1 when A0 is set by intervention to equal a0. We shall assume that
L1(a0) | A0 = a0, L0, T (a0, 0) > 1 ∼ N(1.6− 0.5a0, 0.5)
The hazard of T (a0, a1) given Ā1, L0 and L1(a0) during time interval t ∈ [1, 2) was
assumed to be
E{dN(a0,a1)(t) | Ā1 = (a0, a1), L0, L(a0), T (a0, a1) > t}
= ω1 + γ10L0 + γ11L1(a0) + δ10a0 + δ11a1 + (t− 1)c t ∈ [1, 2)
where ω1 = 2.7, γ10 = 0, γ11 = 0.75, δ10 = 0.275, δ11 = −0.3 and c is a constant.
We shall consider two values of c: 0 and 9/32. This form of the hazard implies
that Model M1 is correctly specified and ψ1(1) = δ11 = −0.3. Also, Model B0(0)
is correctly specified if c = 0, but not if c = 9/32 (because the intercept term
2.7 + (t − 1)c is then a function of t). However, Model B∗0(0) is correctly specified
regardless of whether c = 0 or c = 9/32 (because the intercept in that model is
allowed to be a function of t).
We shall now show that: i) Model M0 is correctly specified during time interval
36 Biometrics, 000 0000
t ∈ [1, 2), with ψ0(1) = −0.1; ii) Model B0(1) is correctly specified if c = 9/32 but
not if c = 0; and iii) Model B∗0(1) is correctly specified whatever the value of c.
For t ∈ [1, 2),
P{T (a0, 0) > t | A0, L0}
= P{T (a0, 0) > 1 | A0, L0}
×EL1(a0)
[
P{T (a0, 0) > t | Ā1, L1(a0), T (a0, 0) > 1} | A0, L0, T (a0, 0) > 1
]





−{ω1 + (t− 1)c/2 + γ10L0 + γ11L1(a0) + δ10a0} (t− 1)
]
| A0, L0, T (a0, 0) > 1)
= exp
[
− {ω0 + γ00L0 + δ00a0} − {ω1 + (t− 1)c/2 + γ10L0 + δ10a0} (t− 1)
]
×EL1(a0) [exp{−γ11L1(a0) (t− 1)} | A0, L0, T (a0, 0) > 1] (39)
Moreover, because L1(a0) is normally distributed given A0, L0 and T (a0, 0) > 1,
and using the form of the moment generating function of a normal distribution,
we have
EL1(a0) [exp{−γ11L1(a0) (t− 1)} | A0, L0, T (a0, 0) > 1]




Var {γ11L1(a0)(t− 1) | A0, L0, T (a0, 0) > 1}
]




(t− 1)2γ211Var {L1(a0) | A0, L0, T (a0, 0) > 1}
]
(40)
It follows from equations (39) and (40) that the conditional hazard of T (a0, 0)
given A0 and L0 during time interval t ∈ [1, 2) equals
ω1 + (t− 1)c+ γ10L0 + δ10a0 + γ11E {L1(a0) | A0, L0, T (a0, 0) > 1}
−(t− 1)γ211Var {L1(a0) | A0, L0, T (a0, 0) > 1} (41)
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We see from the hazard (41) that Model M0 is correctly specified in the time
interval t ∈ [1, 2), with
ψ0(1) = δ10 + γ11 ×
E {L1(a0) | A0, L0} − E {L1(0) | A0, L0}
a0
= 0.275 + 0.75× (−0.5)
= −0.1
Moreover, if c = γ211Var {L1(a0) | A0, L0, T (a0, 0) > 1} = 0.75
2 × 0.5 = 9/32, the
hazard (41) reduces to
ω1 + γ10L0 + δ10a0 + γ11E {L1(a0) | A0, L0, T (a0, 0) > 1}
= 2.7 + 0× L0 + 0.275a0 + 0.75(1.6− 0.5a0)
= 3.9− 0.1a0
which shows that Model B0(1) is correctly specified if c = 9/32 but not if c = 0. The
more general model, Model B∗0(1), is correctly specified whether c = 0 or c = 9/32.
We generated observed data from this model as follows. First, we need to specify
how to generate L0, A0 and A1.
For L0, we assumed that L0 ∼ N(0, 0.5).
The data-generating distribution of A0 given L0 was either A0 | L0 ∼ N(3 −
L0, 0.9
2) or A0 | L0 ∼ N(3.5 − 2I(L0 > 0.75), 0.9
2), where I(.) is the indicator





The Model A0 that will be assumed when fitting the SNCSTM to these simulated
data is a linear regression of A0 on L0. So, if the data-generating model is A
gen(1)
0




The hazard for the observed failure time T is 2.7+0.75L0− 0.3A0 during the time
interval t ∈ [0, 1).
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To generate L1 given A0, L1 and T > 1, we assumed
L1 | A0, L0, T > 1 ∼ N(1.6− 0.5A0, 0.5)
The true data-generating distribution of A1 given A0, L̄1 and T > 1 was either
A1 | A0, L̄1, T > 1 ∼ N(3−L1, 0.9
2) (called model A
gen(1)
1 ) or A1 | A0, L̄1, T > 1 ∼
N(3.5 − 2I(L1 > 0.75), 0.9
2) (called model A
gen(2)
1 ). The Model A1 that will be
assumed when fitting the SNCSTM to these simulated data is a linear regression
of A1 on A0 and L̄1. So, if the data-generating model is A
gen(1)
1 then Model A1 is
correctly specified, but if it is A
gen(2)
1 then Model A1 is misspecified.
The hazard for the observed failure time T is 2.7+0.75L1+0.275A0−0.3A1+(t−1)c
during the time interval t ∈ [1, 2).
We considered the following four scenarios:




1 . This means
that Models A0 and A1 are correctly specified, and so all of Methods 1–3
should yield consistent estimates of ψ0(0), ψ0(1) and ψ1(1). Here we used c = 0.




1 . This means
that A0 is correctly specified, but A1 is misspecified. Here, Method 1 should
yield a consistent estimate of ψ0(0) but the estimates of ψ0(1) and ψ1(1) may
be inconsistent. We used c = 0, which means Model B1(1) is also correctly
specified. The double robustness properties of Methods 2 and 3 should mean
that these methods yield consistent estimates not only of ψ0(0) but also of ψ0(1)
and ψ1(1).




1 . This means
that A0 is misspecified, but A1 is correctly specified. Here, Method 1 should
yield a consistent estimate of ψ1(1) but the estimates of ψ0(0) and ψ0(1) may be
inconsistent. We used c = 9/32, which means Model B0(1) is correctly specified.
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Since Model B0(0) is also correctly specified, the double robustness properties
of Methods 2 and 3 should mean that these methods yield consistent estimates
of ψ0(0), ψ0(1) and ψ1(1).




1 . This means
that Models A0 and A1 are both misspecified. Here, Method 1 may yield
inconsistent estimates of all three parameters. We used c = 0, which means that
Models B1(1) and B0(0) are correctly specified. Method 2 should therefore yield
consistent estimates of ψ0(0) and ψ1(1). However, Model B0(1) is misspecified,
meaning that the estimate of ψ0(1) from Method 2 may be inconsistent. Method
3 should yield consistent estimates of all three parameters, because Model B∗0(1)
is correctly specified.
For each of these four scenarios, we considered the case of no random censoring and
the case of censoring completely at random with constant censoring hazard 0.5.
Thus, there were a total of eight scenarios. In all eight scenarios, all individuals
who had not failed or been censored prior to time t = 2 were administratively
censored at that time. For each scenario, we generated 5000 simulated datasets,
each of n = 5000 individuals.
Table 18 shows the mean of the parameter estimates over the 5000 simulated
datasts when there is no censoring. Results for the random censoring scenarios were
very similar. Monte Carlo standard errors for these means are shown in brackets.
The results are as expected. That is, where we have predicted an estimator to be
consistent, it is approximately unbiased, and where it has been predicted to be
possibly inconsistent, it is generally biased. One exception is that the bias (if any)
in the estimator of ψ0(1) from Method 2 is very small even in the fourth scenario,
where we predicted this estimator was likely to be inconsistent. This is probably
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because the misspecification of Model B0(1) is only minor, i.e. only the intercept
term depends on t and this dependence is not large.
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Figure 2. Expectations of unweighted (solid line) and weighted estimating
function (broken line) as functions of ψ0(0). The true value of ψ0(0) is shown by
the vertical dotted line.
Table 1
Means (×10) and SEs (×10) of parameter estimates when n = 1000, visits are regular and the only
censoring is administrative. ‘Mtd’ is method (‘P’ is Picciotto et al.’s method — see Section 9) and
‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
Means
1 no 0.393 0.098 0.031 0.025 0.391 0.096 0.034 0.403 0.098 0.383
2 no 0.396 0.100 0.032 0.024 0.394 0.097 0.033 0.408 0.100 0.392
3 no 0.395 0.100 0.031 0.023 0.392 0.096 0.033 0.406 0.099 0.388
P no 0.394 0.107 0.030 0.021 0.394 0.094 0.049 0.408 0.102 0.387
1 yes 0.386 0.096 0.032 0.024 0.386 0.096 0.032 0.386 0.096 0.386
2 yes 0.397 0.099 0.032 0.023 0.397 0.099 0.032 0.397 0.099 0.397
3 yes 0.395 0.098 0.032 0.023 0.395 0.098 0.032 0.395 0.098 0.395
P yes 0.394 0.104 0.030 0.029 0.394 0.104 0.030 0.394 0.104 0.394
SEs
1 no 0.177 0.187 0.199 0.218 0.243 0.254 0.260 0.251 0.273 0.272
2 no 0.169 0.180 0.191 0.204 0.237 0.246 0.253 0.240 0.262 0.267
3 no 0.169 0.179 0.190 0.204 0.236 0.245 0.252 0.239 0.260 0.265
P no 0.196 0.290 0.349 0.397 0.265 0.376 0.452 0.270 0.384 0.300
1 yes 0.113 0.131 0.158 0.217 0.113 0.131 0.158 0.113 0.131 0.113
2 yes 0.109 0.129 0.151 0.203 0.109 0.129 0.151 0.109 0.129 0.109
3 yes 0.109 0.128 0.150 0.203 0.109 0.128 0.150 0.109 0.128 0.109
P yes 0.126 0.206 0.306 0.494 0.126 0.206 0.306 0.126 0.206 0.126
Table 2
Means (×10) and SEs (×10) of parameter estimates when n = 1000, visits are regular and censoring is
random. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weights; ‘P’ is Picciotto et al.’s method —
see Section 9) and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
Means
1 no 0.394 0.108 0.021 0.054 0.396 0.105 0.055 0.403 0.111 0.383
1cw no 0.396 0.102 0.020 0.054 0.393 0.096 0.054 0.408 0.097 0.383
2 no 0.396 0.104 0.036 0.033 0.399 0.096 0.038 0.411 0.098 0.393
3 no 0.396 0.103 0.036 0.033 0.396 0.095 0.038 0.407 0.096 0.385
P no 0.397 0.117 0.024 0.050 0.399 0.095 0.078 0.405 0.117 0.390
1 yes 0.391 0.106 0.031 0.053 0.391 0.106 0.031 0.391 0.106 0.391
1cw yes 0.392 0.099 0.031 0.054 0.392 0.099 0.031 0.392 0.099 0.392
2 yes 0.398 0.099 0.037 0.032 0.398 0.099 0.037 0.398 0.099 0.398
3 yes 0.396 0.099 0.037 0.032 0.396 0.099 0.037 0.396 0.099 0.396
P yes 0.395 0.108 0.035 0.051 0.395 0.108 0.035 0.395 0.108 0.395
SEs
1 no 0.265 0.313 0.372 0.467 0.400 0.483 0.569 0.462 0.563 0.577
1cw no 0.201 0.234 0.373 0.469 0.298 0.346 0.572 0.348 0.424 0.406
2 no 0.180 0.211 0.252 0.304 0.276 0.313 0.380 0.317 0.385 0.373
3 no 0.180 0.211 0.251 0.303 0.275 0.310 0.375 0.314 0.380 0.367
P no 0.219 0.389 0.571 0.728 0.334 0.557 0.855 0.385 0.652 0.457
1 yes 0.186 0.241 0.311 0.463 0.186 0.241 0.311 0.186 0.241 0.186
1cw yes 0.140 0.179 0.313 0.465 0.140 0.179 0.313 0.140 0.179 0.140
2 yes 0.130 0.162 0.211 0.303 0.130 0.162 0.211 0.130 0.162 0.130
3 yes 0.130 0.161 0.210 0.301 0.130 0.161 0.210 0.130 0.161 0.130
P yes 0.157 0.282 0.475 0.802 0.157 0.282 0.475 0.157 0.282 0.157
Table 3
Coverage (%) of 95% bootstrap confidence intervals for Methods 1, 2 and 1cw (i.e. Method 1 with
censoring weights) when n=1000, visits are regular, either there is only administrative censoring or
there is random censoring, and the constraint ψk(k+m) = ψk′(k′+m) is not imposed.
Mtd ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
No censoring
1 96.0 96.0 95.5 94.7 94.4 95.5 96.6 95.4 95.7 94.5
2 96.5 96.4 95.4 95.7 94.9 95.6 96.5 96.0 95.8 94.7
Random censoring
1 95.0 95.6 96.4 94.8 95.3 95.5 95.9 95.6 96.0 95.4
1cw 96.5 96.8 96.6 95.2 95.9 97.9 95.9 97.1 97.8 97.7
2 95.7 95.7 95.9 96.1 94.9 95.9 96.7 95.9 96.6 96.1
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.394 0.112 0.009 0.024 0.399 0.118 0.034 0.382 0.133 0.354
1cw no 0.390 0.110 0.009 0.025 0.418 0.106 0.036 0.397 0.136 0.351
2 no 0.398 0.110 0.034 0.026 0.401 0.096 0.020 0.413 0.114 0.408
1 yes 0.392 0.116 0.026 0.024 0.392 0.116 0.026 0.392 0.116 0.392
1cw yes 0.395 0.112 0.027 0.025 0.395 0.112 0.027 0.395 0.112 0.395
2 yes 0.401 0.107 0.029 0.027 0.401 0.107 0.029 0.401 0.107 0.401
Table 4
Means (×10) of parameter estimates when n=1000 and visits are irregular and there is random
censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.486 0.645 0.828 0.555 0.722 1.044 1.013 0.875 1.144 1.057
1cw no 0.453 0.617 0.831 0.556 0.656 1.001 1.015 0.797 1.098 0.997
2 no 0.180 0.214 0.245 0.277 0.265 0.315 0.378 0.305 0.374 0.355
1 yes 0.355 0.490 0.646 0.543 0.355 0.490 0.646 0.355 0.490 0.355
1cw yes 0.325 0.465 0.646 0.545 0.325 0.465 0.646 0.325 0.465 0.325
2 yes 0.125 0.161 0.204 0.273 0.125 0.161 0.204 0.125 0.161 0.125
Table 5
SEs (×10) of parameter estimates when n=1000 and visits are irregular and there is random censoring.
‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.396 0.098 0.034 0.037 0.397 0.118 0.005 0.393 0.100 0.375
2 no 0.405 0.100 0.042 0.037 0.423 0.128 0.013 0.423 0.106 0.408
3 no 0.403 0.099 0.042 0.037 0.417 0.125 0.014 0.412 0.103 0.393
1 yes 0.362 0.099 0.028 0.037 0.362 0.099 0.028 0.362 0.099 0.362
2 yes 0.410 0.109 0.037 0.036 0.410 0.109 0.037 0.410 0.109 0.410
3 yes 0.403 0.107 0.037 0.036 0.403 0.107 0.037 0.403 0.107 0.403
Table 6
Means (×10) of parameter estimates when n=250 and visits are regular and there is no random
censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.377 0.372 0.416 0.448 0.473 0.492 0.543 0.514 0.571 0.549
2 no 0.363 0.359 0.407 0.439 0.474 0.491 0.540 0.521 0.584 0.574
3 no 0.361 0.356 0.404 0.433 0.467 0.482 0.528 0.508 0.568 0.554
1 yes 0.227 0.249 0.304 0.443 0.227 0.249 0.304 0.227 0.249 0.227
2 yes 0.235 0.255 0.310 0.434 0.235 0.255 0.310 0.235 0.255 0.235
3 yes 0.232 0.251 0.306 0.429 0.232 0.251 0.306 0.232 0.251 0.232
Table 7
SEs (×10) of parameter estimates when n=250 and visits are regular and there is no random censoring.
‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.409 0.115 0.015 -0.003 0.388 0.076 -0.034 0.397 0.153 0.354
1cw no 0.399 0.107 0.021 -0.005 0.373 0.105 -0.037 0.408 0.121 0.354
2 no 0.404 0.107 0.050 0.051 0.419 0.115 0.020 0.439 0.101 0.403
3 no 0.401 0.106 0.050 0.049 0.411 0.114 0.024 0.422 0.094 0.376
1 yes 0.382 0.108 0.005 -0.002 0.382 0.108 0.005 0.382 0.108 0.382
1cw yes 0.373 0.105 0.010 -0.005 0.373 0.105 0.010 0.373 0.105 0.373
2 yes 0.409 0.108 0.049 0.046 0.409 0.108 0.049 0.409 0.108 0.409
3 yes 0.401 0.106 0.049 0.044 0.401 0.106 0.049 0.401 0.106 0.401
Table 8
Means (×10) of parameter estimates when n=250 and visits are regular and there is random censoring.
‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.544 0.638 0.765 0.948 0.840 0.949 1.197 0.967 1.161 1.203
1cw no 0.431 0.482 0.778 0.974 0.633 0.711 1.230 0.741 0.926 0.911
2 no 0.387 0.422 0.524 0.671 0.585 0.659 0.866 0.707 0.885 0.898
3 no 0.385 0.418 0.516 0.655 0.575 0.641 0.832 0.683 0.830 0.840
1 yes 0.383 0.474 0.616 0.902 0.383 0.474 0.616 0.383 0.474 0.383
1cw yes 0.294 0.355 0.632 0.938 0.294 0.355 0.632 0.294 0.355 0.294
2 yes 0.280 0.325 0.432 0.644 0.280 0.325 0.432 0.280 0.325 0.280
3 yes 0.276 0.317 0.424 0.630 0.276 0.317 0.424 0.276 0.317 0.276
Table 9
SEs (×10) of parameter estimates when n=250 and visits are regular and there is random censoring.
‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.448 0.074 0.043 -0.045 0.387 0.161 0.028 0.294 0.126 0.374
1cw no 0.440 0.089 0.044 -0.049 0.381 0.146 0.025 0.289 0.124 0.400
2 no 0.423 0.090 0.043 -0.022 0.439 0.124 0.054 0.422 0.113 0.442
1 yes 0.403 0.117 0.030 -0.029 0.403 0.117 0.030 0.403 0.117 0.403
1cw yes 0.401 0.120 0.030 -0.031 0.401 0.120 0.030 0.401 0.120 0.401
2 yes 0.425 0.099 0.045 -0.021 0.425 0.099 0.045 0.425 0.099 0.425
Table 10
Means (×10) of parameter estimates when n=250 and visits are irregular and there is random
censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.956 1.356 1.661 1.253 1.422 2.148 1.941 1.746 2.309 2.001
1cw no 0.885 1.315 1.670 1.266 1.344 2.059 1.972 1.639 2.238 1.895
2 no 0.381 0.433 0.533 0.715 0.558 0.715 0.898 0.732 0.943 0.892
1 yes 0.695 1.039 1.234 1.135 0.695 1.039 1.234 0.695 1.039 0.695
1cw yes 0.646 1.000 1.256 1.161 0.646 1.000 1.256 0.646 1.000 0.646
2 yes 0.262 0.337 0.450 0.687 0.262 0.337 0.450 0.262 0.337 0.262
Table 11
SEs (×10) of parameter estimates when n=250 and visits are irregular and there is random censoring.
‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting) and ‘Con’ is whether constraint
ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.393 0.099 0.028 0.005 0.391 0.070 0.036 0.396 0.111 0.386
2 no 0.396 0.103 0.026 0.009 0.395 0.071 0.035 0.406 0.109 0.393
3 no 0.396 0.103 0.026 0.009 0.394 0.071 0.035 0.404 0.109 0.390
1 yes 0.369 0.089 0.030 0.004 0.369 0.089 0.030 0.369 0.089 0.369
2 yes 0.397 0.096 0.029 0.008 0.397 0.096 0.029 0.397 0.096 0.397
3 yes 0.396 0.096 0.029 0.008 0.396 0.096 0.029 0.396 0.096 0.396
Table 12
Means (×10) of parameter estimates when n=1000, times between visits are divided by four and visits
are regular and there is no random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring
weighting) and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.355 0.339 0.318 0.326 0.433 0.428 0.428 0.431 0.427 0.422
2 no 0.342 0.323 0.310 0.312 0.417 0.407 0.415 0.409 0.407 0.411
3 no 0.341 0.322 0.310 0.312 0.416 0.405 0.413 0.407 0.405 0.409
1 yes 0.201 0.218 0.245 0.325 0.201 0.218 0.245 0.201 0.218 0.201
2 yes 0.200 0.216 0.243 0.311 0.200 0.216 0.243 0.200 0.216 0.200
3 yes 0.200 0.215 0.242 0.311 0.200 0.215 0.242 0.200 0.215 0.200
Table 13
SEs (×10) of parameter estimates when n=1000, times between visits are divided by four and visits are
regular and there is no random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting)
and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.391 0.093 0.027 0.021 0.394 0.068 0.028 0.399 0.088 0.396
1cw no 0.396 0.100 0.027 0.020 0.398 0.063 0.028 0.408 0.099 0.400
2 no 0.394 0.104 0.028 0.009 0.398 0.073 0.044 0.404 0.104 0.401
3 no 0.394 0.104 0.027 0.009 0.396 0.073 0.044 0.402 0.104 0.398
1 yes 0.381 0.082 0.026 0.020 0.381 0.082 0.026 0.381 0.082 0.381
1cw yes 0.387 0.087 0.027 0.019 0.387 0.087 0.027 0.387 0.087 0.387
2 yes 0.398 0.096 0.034 0.008 0.398 0.096 0.034 0.398 0.096 0.398
3 yes 0.396 0.096 0.034 0.008 0.396 0.096 0.034 0.396 0.096 0.396
Table 14
Means (×10) of parameter estimates when n=1000, times between visits are divided by four and visits
are regular and there is random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring
weighting) and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 0.502 0.507 0.502 0.532 0.635 0.672 0.693 0.669 0.677 0.680
1cw no 0.380 0.378 0.503 0.534 0.471 0.487 0.694 0.481 0.508 0.485
2 no 0.346 0.332 0.330 0.339 0.429 0.433 0.449 0.430 0.452 0.444
3 no 0.346 0.332 0.329 0.338 0.427 0.431 0.447 0.428 0.450 0.440
1 yes 0.302 0.339 0.402 0.530 0.302 0.339 0.402 0.302 0.339 0.302
1cw yes 0.224 0.251 0.404 0.533 0.224 0.251 0.404 0.224 0.251 0.224
2 yes 0.206 0.226 0.260 0.336 0.206 0.226 0.260 0.206 0.226 0.206
3 yes 0.206 0.226 0.259 0.336 0.206 0.226 0.259 0.206 0.226 0.206
Table 15
SEs (×10) of parameter estimates when n=1000, times between visits are divided by four and visits are
regular and there is random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting)
and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
True 0.400 0.100 0.040 0.020 0.400 0.100 0.040 0.400 0.100 0.400
1 no 0.339 0.097 0.004 0.020 0.514 0.056 0.032 0.396 0.048 0.400
1cw no 0.338 0.101 0.004 0.020 0.515 0.054 0.033 0.391 0.063 0.397
2 no 0.391 0.095 0.031 0.006 0.396 0.092 0.030 0.416 0.112 0.405
1 yes 0.402 0.075 0.019 0.020 0.402 0.075 0.019 0.402 0.075 0.402
1cw yes 0.400 0.081 0.018 0.020 0.400 0.081 0.018 0.400 0.081 0.400
2 yes 0.399 0.099 0.030 0.007 0.399 0.099 0.030 0.399 0.099 0.399
Table 16
Means (×10) of parameter estimates when n=1000, times between visits are divided by four and visits
are irregular and there is random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring
weighting) and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
Mtd Con ψ0(0) ψ0(1) ψ0(2) ψ0(3) ψ1(1) ψ1(2) ψ1(3) ψ2(2) ψ2(3) ψ3(3)
1 no 1.589 1.923 2.026 0.753 1.967 2.670 2.217 2.197 2.695 2.458
1cw no 1.559 1.894 2.031 0.755 1.920 2.629 2.220 2.162 2.642 2.413
2 no 0.342 0.347 0.324 0.356 0.420 0.441 0.461 0.453 0.429 0.444
1 yes 1.021 1.312 1.512 0.729 1.021 1.312 1.512 1.021 1.312 1.021
1cw yes 0.999 1.298 1.515 0.733 0.999 1.298 1.515 0.999 1.298 0.999
2 yes 0.201 0.233 0.266 0.354 0.201 0.233 0.266 0.201 0.233 0.201
Table 17
SEs (×10) of parameter estimates when n=1000, times between visits are divided by four and visits are
irregular and there is random censoring. ‘Mtd’ is method (‘1cw’ is Method 1 with censoring weighting)
and ‘Con’ is whether constraint ψk(k+m) = ψk′(k′+m) is imposed.
A0 A1 Mtd ψ0(0) ψ0(1) ψ1(1)
True 0.300 0.100 0.300
correct correct 1 0.293 (0.000) 0.101 (0.002) 0.298 (0.001)
2 0.295 (0.000) 0.101 (0.001) 0.301 (0.001)
3 0.295 (0.000) 0.101 (0.001) 0.300 (0.001)
correct misspec 1 0.292 (0.000) 0.104 (0.001) 0.262 (0.001)
2 0.294 (0.000) 0.100 (0.001) 0.301 (0.001)
3 0.294 (0.000) 0.100 (0.001) 0.302 (0.001)
misspec correct 1 0.262 (0.000) 0.087 (0.001) 0.298 (0.001)
2 0.298 (0.000) 0.104 (0.001) 0.302 (0.001)
3 0.300 (0.000) 0.104 (0.001) 0.301 (0.001)
misspec misspec 1 0.262 (0.000) 0.088 (0.001) 0.262 (0.001)
2 0.298 (0.000) 0.102 (0.001) 0.300 (0.001)
3 0.300 (0.000) 0.101 (0.001) 0.301 (0.001)
Table 18
Results from simulation study to investigate double robustness of Methods 2 and 3. Mean estimates
(×− 1) over 5000 simulated datasets are shown, along with Monte Carlo standard errors of these means
(in brackets). ‘Mtd’ means method. Numbers in red indicate estimators expected to be inconsistent.
